US20060184221A1 - Trans-septal catheter with retention mechanism - Google Patents
Trans-septal catheter with retention mechanism Download PDFInfo
- Publication number
- US20060184221A1 US20060184221A1 US11/399,865 US39986506A US2006184221A1 US 20060184221 A1 US20060184221 A1 US 20060184221A1 US 39986506 A US39986506 A US 39986506A US 2006184221 A1 US2006184221 A1 US 2006184221A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- ablation
- heart chamber
- guide catheter
- septum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000014759 maintenance of location Effects 0.000 title abstract description 38
- 230000007246 mechanism Effects 0.000 title abstract description 35
- 210000005242 cardiac chamber Anatomy 0.000 claims abstract description 59
- 238000002679 ablation Methods 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 34
- 230000001746 atrial effect Effects 0.000 claims description 17
- 210000001519 tissue Anatomy 0.000 claims description 9
- 210000002837 heart atrium Anatomy 0.000 claims description 7
- 210000005003 heart tissue Anatomy 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 4
- 230000002107 myocardial effect Effects 0.000 claims description 3
- 238000002604 ultrasonography Methods 0.000 claims description 3
- 210000001367 artery Anatomy 0.000 claims description 2
- 210000004013 groin Anatomy 0.000 claims description 2
- 230000003902 lesion Effects 0.000 claims description 2
- 210000003462 vein Anatomy 0.000 claims description 2
- 210000005246 left atrium Anatomy 0.000 description 47
- 210000005245 right atrium Anatomy 0.000 description 39
- 238000013507 mapping Methods 0.000 description 26
- 230000007831 electrophysiology Effects 0.000 description 20
- 238000002001 electrophysiology Methods 0.000 description 20
- 230000037361 pathway Effects 0.000 description 15
- 210000002216 heart Anatomy 0.000 description 12
- 208000001871 Tachycardia Diseases 0.000 description 7
- 230000006794 tachycardia Effects 0.000 description 7
- 208000003734 Supraventricular Tachycardia Diseases 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 230000003126 arrythmogenic effect Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000005240 left ventricle Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 206010003658 Atrial Fibrillation Diseases 0.000 description 4
- 208000006808 Atrioventricular Nodal Reentry Tachycardia Diseases 0.000 description 4
- 238000007674 radiofrequency ablation Methods 0.000 description 4
- 210000001631 vena cava inferior Anatomy 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 238000005452 bending Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 210000003492 pulmonary vein Anatomy 0.000 description 3
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 3
- 208000003663 ventricular fibrillation Diseases 0.000 description 3
- 206010047302 ventricular tachycardia Diseases 0.000 description 3
- 241000703391 Lipovnik virus Species 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 238000013153 catheter ablation Methods 0.000 description 2
- 210000003748 coronary sinus Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000004971 interatrial septum Anatomy 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 210000004115 mitral valve Anatomy 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 210000000591 tricuspid valve Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000002620 vena cava superior Anatomy 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 206010003662 Atrial flutter Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 210000003157 atrial septum Anatomy 0.000 description 1
- 210000001992 atrioventricular node Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- -1 e.g. Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- OCDRLZFZBHZTKQ-NMUBGGKPSA-N onetine Chemical compound C[C@@H](O)[C@@]1(O)C[C@@H](C)[C@@](C)(O)C(=O)OC\C2=C\CN(C)CC[C@@H](OC1=O)C2=O OCDRLZFZBHZTKQ-NMUBGGKPSA-N 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000003102 pulmonary valve Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 210000000596 ventricular septum Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
- A61B2017/00252—Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
Definitions
- the present invention relates generally to trans-septal introducers or guide catheters adapted to introduce an instrument through the septum between a left and right heart chamber, and more particularly, the present invention relates to a trans-septal guide catheter having a retention mechanism for retaining the distal end of the guide catheter within the left heart chamber particularly to enable passage therethrough of an electrophysiology (EP) catheter.
- EP electrophysiology
- Tachycardia that is abnormally rapid rhythms of the heart, are caused by the presence of an arrhythmogenic site or accessory pathway, which bypasses or short circuits the nodal pathways in the heart.
- Tachycardias may be categorized as ventricular tachycardias (VTs) or supraventricular tachycardias (SVTs).
- VTs ventricular tachycardias
- SVTs supraventricular tachycardias
- the most common SVT's include atrioventricular nodal reentrant tachycardia (AVNRT), Atrioventricular reentrant tachycardia (AVRT), atrial fibrillation (AF), and atrial flutter (AFI).
- AFI atrial flutter
- Reentrant tachycardias originate in the atria and are typically caused by an accessory pathway or inappropriate premature return excitation from the ventricle through the AV node or left sided accessory pathway. Conditions such as AF and AFI involve either premature excitation from focal ectopic sites within the atria or excitations coming through inter-atrial reentry pathways as well as regions of slow conduction within the atria.
- VT's originate from within the ventricles and have their entire circuit contained within the ventricles. These VT's include bundle branch reentrant tachycardia (BBR), right ventricular outflow tract tachycardia (RVOT), and ventricular fibrillation (VF).
- BBR bundle branch reentrant tachycardia
- RVOT right ventricular outflow tract tachycardia
- VF ventricular fibrillation
- VT's are often caused by arrhythmogenic sites associated with a prior myocardial infarction as well as reentrant pathways between the ventricles.
- BBR involves an inappropriate conduction circuit that uses the right and left bundle branches.
- RVOT can be described as a tachycardia originating from the right ventricular outflow tract, which involves ectopic triggering or reentry mechanisms.
- VF is a life threatening condition where the ventricles entertain a continuous uncoordinated series of contractions that cause a cessation of blood flow from the heart. If normal sinus rhythm is not restored, the condition is terminal.
- Treatment of both SVTs and VTs may be accomplished by a variety of approaches, including drugs, surgery, implantable electrical stimulators, and catheter ablation of cardiac tissue of an effected pathway. While drugs may be the treatment of choice for many patients, drugs typically only mask the symptoms and do not cure the underlying cause. Implantable electrical stimulators, e.g., pacemakers, afferent nerve stimulators and cardioverter/defibrillators, which have proven to provide successful treatment, usually can only correct an arrhythmia after it occurs and is successfully detected. Surgical and catheter-based treatments, in contrast, will actually cure the problem usually by ablating the abnormal arrhythmogenic tissue or accessory pathway responsible for the tachycardia. The catheter-based treatments rely on the application of various destructive energy sources to the target tissue including direct current electrical energy, radio frequency (RF) electrical energy, laser energy, ultrasound, microwaves, and the like.
- RF radio frequency
- RF ablation protocols have proven to be highly effective in treatment of many cardiac arrhythmias while exposing the patient to minimum side effects and risks.
- RF catheter ablation is generally performed after an initial electrophysiologic (EP) mapping procedure is conducted using an EP mapping catheter to locate the arrhythmogenic sites and accessory pathways.
- EP mapping electrophysiologic
- an RF ablation catheter having a suitable electrode is introduced to the appropriate heart chamber and manipulated so that the electrode lies proximate the target tissue.
- catheters designed for mapping and ablation frequently include one or more cylindrical or band-shaped individual electrodes mounted to the distal section of the catheter so as to facilitate mapping of a wider area in less time, or to improve access to target sites for ablation.
- RF energy is then applied through the electrode(s) to the cardiac tissue to ablate a region of the tissue that forms part of the arrhythmogenic site or the accessory pathway.
- mapping and ablation catheters are inserted into a major vein or artery, usually in the neck or groin area, and guided into the chambers of the heart by appropriate manipulation through a venous or arterial route, respectively.
- the catheter must have a great deal of flexibility or steerability to be advanced through the vascular system into a chamber of the heart, and the catheter must permit user manipulation of the tip even when the catheter body traverses a curved and twisted vascular access pathway.
- Such catheters must facilitate manipulation of the distal tip so that the distal electrode(s) can be positioned and held against the tissue region to be mapped or ablated.
- the arrhythmogenic sites or accessory pathways to be mapped and ablated frequently occur within the left atrial wall, particularly around pulmonary vein orifices. It is preferable in such cases to introduce an instrument into the right atrium by a venous route including the inferior vena cava and to advance it through the septum separating the right and left atrium.
- a guide catheter is inserted in this manner into the right atrium, and instruments are introduced through the guide catheter lumen that are manipulated from their proximal end and advanced through the septal wall first creating a very small trans-septal perforation, and then enlarging the perforation by dilation or the like.
- the guide catheter is then advanced over the instruments or advanced directly through the perforation in the septal wall to locate the guide catheter distal end within the left atrial chamber.
- the penetrating instruments are retracted from the guide catheter lumen.
- the proximal end of the guide catheter is typically taped to the patient's body or a support to inhibit retraction back into the right atrial chamber.
- the mapping and ablation catheters are then inserted through the guide catheter lumen to locate their distal segments within the left atrial chamber.
- mapping and ablation procedures are undertaken, the mapping and ablation catheters are retracted, and the guide catheter is also retracted.
- the trans-septal perforation tends to shrink as the dilated myocardial tissue expands across the perforation.
- the guide catheter can be inadvertently dislodged by movements of the proximal segment emerging from the site of incision.
- the dislodgement can require withdrawal of the instruments in use, jeopardizing their sterility, while delay occurs in reestablishing catheter position and resumption of the procedure.
- the only way to monitor the location of the distal segment of the guide catheter is through visualization of a radiopaque marker of the guide catheter in regard to recognizable physiologic features of the heart.
- the distal end segment of the electrophysiology catheter be directed at an acute angle just as it exits the guide catheter lumen to be directed toward certain features of the left atrium. Therefore, only a very short distal segment of the guide catheter is extended into the left atrium past the septum so that the electrophysiology catheter can be directed to the feature of interest. It is more difficult to maintain the distal segment within the left atrium as the distal segment within the left atrium is shortened.
- the present invention is directed to an improved trans-septal guide catheter that can be passed through a septum from one heart chamber to another heart chamber and that possesses a retention mechanism for maintaining a distal segment thereof in the other heart chamber.
- the trans-septal guide catheter can be introduced into the right atrium, passed through the atrial septum into the left atrium to locate a distal segment thereof within the left atrium, and retained within the left atrium so that the distal segment does not readily retract through the septum into the right atrium.
- the trans-septal guide catheter provides access through the septum separating a right heart chamber from a left heart chamber and preferably includes an elongated guide catheter body extending between guide catheter proximal and distal ends enclosing a guide catheter lumen adapted to provide access into the left heart chamber through a guide catheter lumen proximal end opening and a guide catheter lumen distal end opening. Retention mechanisms are provided for engaging the septum and inhibiting retraction through the septum of the distal segment of the guide catheter extending into the left heart chamber.
- the trans-septal guide catheter particularly enables passage of an EP catheter through the guide catheter lumen for use in mapping and/or ablation of accessory pathways in myocardial tissue of the left atrial heart wall.
- the retention mechanism further includes at least one flexible, pliant, tine extending outwardly from a tine attachment with the distal segment of the guide catheter body to a tine free end.
- the tine free end is adapted to deflect inward toward the guide catheter body when restrained during advancement of the guide catheter and to extend further outward from the guide catheter body when restrained against the septal wall when any retraction force is applied to the guide catheter tending to retract the distal segment of the guide catheter body back into the right heart chamber.
- the retention mechanism includes an inflatable balloon inflated and deflated through an inflation and deflation lumen within the guide catheter body extending from a proximal inflation port at the guide catheter proximal end to a balloon inflation port within the inflatable balloon.
- the inflation medium is introduced through the balloon inflation and deflation lumen to inflate the balloon after the balloon is advanced through the septum into the left heart chamber.
- the inflated balloon bears against the septal wall and inhibits retraction through the septum of the distal segment of the guide catheter extending into the left heart chamber.
- the retention mechanism includes a wire that is extendable through a wire deployment lumen of the catheter body.
- a distal wire segment has a non-straight configuration when extended out of the deployment lumen end opening and into engagement with the septal wall of the septum within the left heart chamber that inhibits retraction through the septum of the distal segment of the guide catheter extending into the left heart chamber and is straightened when advanced through the wire deployment lumen.
- the non-straight configuration of the retention wire can include a wire coil formed of a plurality of wire turns of a coil, e.g., a planar coil, or an acute bend in the wire.
- the retention wire can be formed of a shape memory alloy to possess superelasticity that enables straightening of the non-straight configuration within the wire deployment lumen.
- the guide catheters of the present invention solve the problem of maintaining the distal segment thereof in the heart chamber that the distal segment is introduced into and enables shortening of the length of the distal segment to enable maximal access to features of the heart chamber, particularly the left atrium.
- the retention mechanisms ensure that vent ports in the sidewall of the guide catheter body distal segment are within the heart chamber that the distal segment is introduced into and are not obstructed by the septum.
- the retention mechanisms are preferably located to be deployed or self deploy in the heart chamber that the distal segment is introduced into to inhibit retraction when retraction force is applied to the guide catheter proximal end drawing the retention mechanism against the septal wall. It will be understood that the deployment mechanisms can be deployed more proximally to the guide catheter body distal segment to bear against the septal wall when advancement force is applied to the guide catheter proximal end. Slight force can then be applied to hold the catheter in position without advancing the guide catheter further into the accessed heart chamber. Moreover, it would be possible to duplicate the retention mechanism to deploy a retention mechanism on either side of the septum.
- FIG. 1 is an overall view of one embodiment of an ablation and/or EP mapping catheter that can be passed through a guide catheter of the present invention
- FIG. 2 is a schematic illustration of the introduction of the ablation and/or EP mapping catheter distal section into the left atrium through the lumen of a guide catheter extending through an incision or perforation through the septum between the right and left atrium;
- FIG. 3 is a simplified schematic illustration of a first embodiment of a guide catheter of the present invention having a deployable retention mechanism comprising an expandable balloon expanded in the left atrium and drawn against the septal wall in the left atrium to inhibit retraction of the guide catheter distal segment into the right atrium;
- FIG. 4 is a cross-section view along lines 4 - 4 of FIG. 3 depicting the guide catheter lumen and balloon inflation/deflation lumen;
- FIG. 5 is a simplified schematic illustration of a second embodiment of a guide catheter of the present invention having a retention mechanism comprising a plurality of pliant tines drawn against the septal wall in the left atrium to inhibit retraction of the guide catheter distal segment into the right atrium;
- FIG. 6 is an end view of the distal segment of the guide catheter of FIG. 5 depicting the guide catheter lumen and outwardly extending tines;
- FIG. 7 is a simplified schematic illustration of a third embodiment of a guide catheter of the present invention having a deployable retention mechanism comprising an extendable wire that forms a wire coil when extended from a wire deployment lumen into the left atrium and inhibits retraction of the guide catheter distal segment into the right atrium;
- FIG. 8 is a simplified schematic illustration of the third embodiment of a guide catheter of the present invention showing the extendable wire that forms the wire coil when extended into the left atrium retracted into the wire deployment lumen during introduction or withdrawal of the distal segment through the septum into or from the left atrium;
- FIG. 9 is a simplified schematic illustration of a fourth embodiment of a guide catheter of the present invention having a deployable retention mechanism comprising an extendable wire that bends over at an acute angle when extended from a wire lumen into the left atrium and inhibits retraction of the guide catheter distal segment into the right atrium;
- FIG. 10 is a simplified schematic illustration of the fourth embodiment of a guide catheter of the present invention showing the extendable wire that bends over when extended into the left atrium retracted into the wire deployment lumen during introduction or withdrawal of the distal segment through the septum into or from the left atrium;
- FIG. 11 is an expanded view of the distal end segment of the extendable wire of FIGS. 9 and 10 ;
- FIG. 12 is a cross-section view along lines 12 - 12 of FIGS. 7-10 depicting the guide catheter lumen and one embodiment of the extendable wire lumen and extendable wire cross-section.
- FIG. 1 schematically illustrates an anatomically-conforming, multi-curve ablation and/or EP mapping catheter 10 that can be introduced through a guide catheter of the present invention for orienting a distal tip electrode 12 (or electrodes) with respect to the heart wall for RF ablation and/or EP mapping.
- the multi-curve catheter 10 can incorporate a porous tip and catheter lumen for emitting irrigating fluid around the distal tip electrode 12 , but those features are not illustrated in FIG. 1 to simplify illustration.
- the distal segment 32 is simplified in FIG. 1 to show an elongated tubular shaped ablation electrode 12 and a pair of mapping electrodes 13 and 15 in the illustration of FIG.
- the distal segment 32 may include a plurality of ring-shaped electrodes, one or more coil electrode or the like having other shapes that are presently used or may come into use and including several variations described below in reference to other figures including visible or invisible light, infrared, and electrical energy from or along the distal tip.
- the catheter 10 includes a catheter shaft or body 20 and a handle 40 .
- the catheter shaft or body 20 has a shaft axis 24 and extends between a distal end 26 and a proximal end 28 and is separated into a proximal section 22 and a distal section 30 .
- Catheter body 20 may be of any suitable diameter and length and may be straight or pre-curved along its length, but preferably is straight when unrestrained.
- the distal section 30 or the distal segment thereof can be tapered from the diameter of the proximal section 22 .
- the catheter body 20 has a uniform outside diameter of about 0.052 inch (1.32 mm) to 0.1040 inch (2.64 mm) and a length of about 50 cm to 110 cm.
- the proximal section 22 has sufficient column strength and is capable of good torque transmission to permit controlled placement of the distal section 30 at a target site in the heart including a selected cardiac valve or vessel in the manners discussed below.
- the distal section 30 is deflectable away from shaft axis 24 and includes a distal segment 32 , a curvable proximal segment 36 having a proximal segment length, and a bendable intermediate segment 34 having an intermediate segment length disposed between the distal segment 32 and the curvable proximal segment 36 .
- the illustrative tip electrode 12 is positioned along the distal segment 32 , preferably extending proximally from the catheter body distal end 26 through all or part of the length of the distal segment 32 .
- the distal segment 32 can include an elongated ablation electrode 12 that may be solid or irrigated and can include one or more proximal ring electrodes 13 , 15 for use in mapping that are either located proximally as shown or distally from ablation electrode 12 .
- Each electrode is separately connected to insulated conductors extending proximally through the catheter body 20 to terminals of a cable connector in or on the handle 40 that is connected via a cable to the ablation energy source and/or mapping signal amplifiers.
- thermocouple is also typically included in the distal segment 32 of such ablation catheters, and separately insulated thermocouple conductors extending proximally through the catheter body 20 to terminals of the cable connector in or on the handle 40 that are coupled via a cable to the temperature display and ablation energy control apparatus known in the art.
- the handle 40 can take any of the forms known in the art for making electrical connections with the conductors within the catheter body 20 , for delivering irrigation fluid to an irrigation lumen (if present) of the catheter body 20 .
- the handle 40 also includes a mechanism for deflecting the distal tip section 30 into the shapes provided by the present invention.
- the mechanism can take any form for pulling, pushing and/or twisting the deflection or push/pull wires within the catheter body 20 as described further below.
- the handle 40 is attached to the catheter body proximal end 28 and supports axially slidable manipulators comprising push-pull rings 44 and 46 and a rotatable lateral deflection ring 42 that are coupled to the proximal ends of a curve deflection push-pull wire, a knuckle deflection push-pull wire, and a lateral deflection wire identified and described further below.
- the lateral deflection ring 42 can be rotated to impart a torque in a lateral deflection wire coupled thereto to laterally rotate the distal section 30 with respect to axis 24 within the proximal section 22 .
- the distal segment 32 , the bendable intermediate segment 34 , and the curvable proximal segment 36 are aligned with the shaft axis 24 that is referenced as 0°.
- the knuckle deflection push-pull wire can be retracted or pulled by sliding ring 46 proximally to impart a small radius bend from substantially 0°, wherein the distal and proximal segments 32 and 36 are axially aligned, to substantially 180°, whereby the distal and proximal segments 32 and 36 are substantially in side-by-side alignment.
- the knuckle deflection push-pull wire can be extended or pushed by sliding push-pull ring 46 distally to impart a small radius bend from substantially 0° to about ⁇ 90°, that is in a bend direction opposite to the bend direction imparted when the knuckle deflection push-pull wire is retracted or pulled by sliding ring 46 proximally.
- the intermediate segment 34 is bent in a bending radius of between 2.0 mm and 7.0 mm, and preferably less than about 5.0 mm within the bending angle range.
- the abrupt knuckle bend angle range can be restricted further by positioning of the slide end stops for the push-pull ring 46 during assembly.
- the manipulator push-pull ring 44 can be moved proximally or distally to move the curve deflection push-pull wire coupled thereto proximally or distally to form a curve in the proximal segment 36 that is opposed to or in the same direction as the bend imparted in the intermediate segment 34 .
- the bend or curve of the proximal segment 36 that can be induced relative to the catheter body axis 24 as depicted in the figures can be between ⁇ 90° to +270° relative to the proximal section 22 .
- the curvature range of the proximal segment 36 can be restricted further by position of the slide end stops for the push-pull ring 44 during assembly.
- the knuckle deflection push-pull wire 56 and the curve deflection push-pull wire 54 extend in parallel with and are radially aligned to the catheter body axis 24 along a common radius extending from the catheter body axis 24 through the proximal section 22 and the proximal segment 36 .
- the knuckle deflection push-pull wire 56 is spaced further away from the axis 24 than the curve deflection push-pull wire 54 through the proximal section 22 and proximal segment 36 .
- the distal section of the knuckle deflection push-pull wire 56 traversing the intermediate segment 34 is axially aligned with the axis of the curve deflection push-pull wire 54 in the proximal segment 36 .
- the lateral deflection wire When the ring 42 is rotated clockwise or counterclockwise, the lateral deflection wire is twisted, causing the junction of the proximal and intermediate segments 36 and 34 to rotate. It will be understood from the construction of the lateral deflection wire described below that a lateral deflection of the tip segment 32 and the intermediate segment 34 in the range of ⁇ 90° to +90° with respect to catheter body straight axis 24 can be achieved by such rotation.
- the structure of the catheter body 20 that achieves these angular tip section deflections and the lateral deflection is illustrated in commonly assigned U.S. patent application Ser. No. (P-9288.00), filed Oct. 10, 2000, in the names of Mark T. Stewart et al. for HEART WALL ABLATION/MAPPING CATHETER AND METHOD.
- the guide catheter of the present invention is advantageously employed with this and other ablation and/or EP mapping catheters that are introduced into through the guide catheter lumen that is itself extended from the right atrium through the septum to locate a distal segment of the guide catheter therein as shown in FIG. 2 , for example.
- FIG. 2 is a schematic illustration of the introduction of the ablation and/or EP mapping catheter distal section into the left atrium through the lumen 64 of a guide sheath or catheter 60 extending through an incision or perforation through the septum to locate a guide catheter distal segment 62 within the left atrium.
- FIG. 2 illustrates, in simplified form, a sectioned heart 100 and the major vessels bringing venous blood into the right atrium RA, oxygenated blood into the left atrium (LA) and the aorta and aortic arch ( FIG. 20 ) receiving oxygenated blood from the left ventricle (LV).
- the venous blood is delivered to the RA through the superior vena cava (SVC), the inferior vena cava (IVC) and the coronary sinus (CS) which all open into the right atrium (RA) superior to the annulus of the tricuspid valve leading into the right ventricle.
- Oxygenated blood from the two lungs is delivered into the left atrium by the left and right, inferior and superior, pulmonary veins (LIPV, LSPV, RIPV and RSPV) which are superior to the mitral valve.
- the RA and LA are separated by an inter-atrial septum 68
- the RV and LV are separated by a ventricular septum.
- the tricuspid valve and mitral valve are not shown completely to simplify the figures.
- Accessory pathways develop in several parts of the RA and LA that are reached by the catheter 10 to be mapped and/or ablated in accordance with methods of use thereof.
- Premature activations that cause atrial fibrillation occur frequently in the LA wall, particularly from pulmonary venous foci around the annular orifices of certain or all of the pulmonary veins RIPV, RSPV, LIPV, LSPV shown in FIG. 2 .
- the LA can be accessed in a retrograde manner through the aorta.
- another convenient approach to the LA is via a puncture or perforation made through the inter-atrial septum from the RA.
- the transseptal guide sheath or catheter 60 depicted in FIG. 2 is inserted through the septum 68 via the perforation 66 .
- the EP mapping/ablation catheter 20 is introduced through the guide catheter lumen 64 , and the handle is manipulated to form the distal section 30 with about a +90° knuckle bend made in the intermediate segment and slight positive, neutral or negative curvatures in the range of about ⁇ 45° to +45° in the proximal segment 36 to align the distal tip to locations 2 A, 2 B or 2 C.
- Continuous lesions can be made around the selected pulmonary valve orifice by successively moving the distal electrode to the next location and applying RF ablation energy. The movement can be effected by twisting the distal segment about the catheter body axis using the deflection wire and manipulator.
- the guide catheters of the present invention are formed with a retention mechanism that is deployed to bear against the LA wall around or alongside the perforation 66 .
- the perforation 66 is first formed through the septal wall of the septum 68 , a distal segment of the guide catheter is advanced into the right heart chamber. In this particular case, the guide catheter is advanced through the IVC into the RA and then through the perforation 66 to locate the distal segment in the LA.
- the retention mechanism is deployed or self deploys into engagement with the septum 68 to inhibit retraction of the distal segment of the guide catheter through the perforation 66 back into RA when any retraction force is applied to the guide catheter.
- access is provided to introduce instruments or materials into the LA.
- the preferred use of the guide catheter of the present invention is to introduce a mapping/ablation EP catheter of the type depicted in FIGs. 1 and 2 , for example, into the LA.
- the deployment mechanism is withdrawn or retracted or overcome by applied retraction force to enable withdrawal of the guide catheter through the perforation 66 .
- FIG. 3 is a simplified schematic illustration of a first embodiment of a guide catheter 70 of the present invention having a deployable retention mechanism comprising an expandable balloon 78 expanded in the LA and drawn against the septal wall in the LA of the septum 66 to inhibit retraction of the guide catheter distal segment 76 into the RA.
- FIG. 4 is a cross-section view along lines 4 - 4 of FIG. 3 depicting the guide catheter lumen 72 and balloon inflation/deflation lumen 82 within the guide catheter body 80 .
- the inflatable balloon 78 is inflated and deflated through the inflation/deflation lumen 82 that extends within the guide catheter body 80 from a proximal inflation port 86 at the guide catheter proximal end 74 to a balloon inflation port 84 within the inflatable balloon 78 .
- the inflation medium preferably a fluid, e.g., saline or a radiopaque solution
- the inflation medium is introduced through the balloon inflation/deflation lumen 82 to inflate the balloon 78 after the deflated balloon 78 is advanced through the septum 68 into the LA.
- the inflated balloon 78 bears against the septal wall and resists or inhibits retraction through the septum 66 of the distal segment 76 of the guide catheter 70 extending into the LA.
- the mapping/ablation EP catheter can then be introduced through the guide catheter lumen 72 as depicted in FIG. 2 to map or ablate cardiac tissue.
- guide catheter 70 may include a second expandable balloon 78 a (shown dashed) that is adapted to be expanded in the RA and drawn against the septal wall. This is discussed further below.
- FIG. 5 illustrates a second embodiment of a guide catheter 90 of the present invention having a self deployed retention mechanism that includes a plurality of pliant tines 98 , 100 drawn against the septum in the LA to inhibit retraction of the guide catheter distal segment 96 through the perforation 66 into the RA.
- FIG. 6 is an end view of the distal segment 96 of the guide catheter of FIG. 5 depicting the guide catheter lumen 92 and outwardly extending tines 98 and 100 .
- Each such flexible, pliant, tine 98 , 100 extends outwardly from a tine attachment 102 , 104 with the distal segment of the guide catheter body to a respective tine free end 106 , 108 .
- the flexible, pliant, tines 98 , 100 extend proximally and outwardly from the respective tine attachments 102 , 104 with the guide catheter body 94 at an acute angle to the guide catheter body 94 .
- the tines 98 , 100 can be rectangular or circular in cross-section and can be thinner or thicker than depicted and longer or shorter than depicted.
- the tines 98 , 100 can be formed of a plastic material, polyurethane or silicone rubber.
- the tine free ends 106 and 108 are able to deflect inward toward the guide catheter body 94 by contact against the septum 68 when the guide catheter 90 is advanced through the perforation 66 .
- the tines 98 , 100 extend or spread further outward from the guide catheter body 94 against the septal wall as shown in FIG. 5 when any retraction force is applied to the guide catheter 90 tending to retract the distal segment 96 of the guide catheter body back into the RA. While the tines 98 , 100 resist bending to extend distally, they can be inverted if sufficient retraction force is applied to the guide catheter body 94 at its proximal end in order to retract the distal segment 96 through the perforation 66 .
- tines 98 ' and 100 ' are illustrated in broken lines in FIG. 6 to illustrate four tines in this instance.
- the additional tines 98 ', 100 ' are formed and function in the same manner as tines 98 , 100 as described above.
- FIG. 7 illustrates a third embodiment of a guide catheter 110 of the present invention having a deployable retention mechanism that includes an extendable wire 112 that forms a wire coil 114 when extended from a wire deployment lumen 118 (shown in FIG. 12 ) into the LA and inhibits retraction of the guide catheter distal segment 116 into the RA.
- the catheter body 122 encloses a guide catheter lumen 124 ( FIG. 12 ) adapted to receive a mapping/ablation EP catheter and the wire deployment lumen 118 extending between a deployment lumen proximal end opening and a deployment lumen distal end opening in the distal segment 120 .
- FIG. 8 shows the extendable wire 112 that forms a wire coil 114 when extended into the LA retracted into the wire lumen 118 during introduction into or withdrawal from the RA of the distal segment 116 through the perforation 66 in the septum 68 .
- the elongated retention wire 112 is extended at guide catheter proximal end 126 through the wire deployment lumen 118 to dispose the distal wire segment 114 within the LA as shown in FIG. 7 .
- the distal wire segment 114 is straightened when advanced through the wire deployment lumen 118 but forms a non-straight configuration when extended out of the deployment lumen end opening and into engagement with the septal wall of the septum 68 within the LA that inhibits retraction through the septum of the distal segment 120 extending into the LA.
- the mapping/ablation EP catheter can then be introduced through the guide catheter lumen 124 as depicted in FIG. 2 to map or ablate cardiac tissue.
- the elongated retention wire 112 is retracted as shown in FIG. 8 to enable retraction of the guide catheter distal segment 120 back into the RA.
- the retention wire 112 and wire lumen 118 can have a circular or rectangular cross-section, and the wire coil 114 can be any desired non-straight configuration, e.g., a wire coil formed of a plurality of wire turns wound in a common plane as shown or into any other coil shape.
- the retention wire 112 can be formed of a shape memory alloy that possesses superelasticity that enables straightening of the non-straight configuration within the wire deployment lumen 118 .
- FIGS. 9-11 illustrate a fourth embodiment of a guide catheter 130 of the present invention having a deployable retention mechanism that includes a distal section 134 of extendable wire 132 .
- the distal section 134 bends over at an acute angle at bend 146 when extended from a wire lumen 138 ( FIG. 12 ) into the LA and inhibits retraction of the guide catheter distal segment 140 into the RA by bearing against the septal wall of septum 68 .
- the acute bend 146 in the wire 132 is straightened during advancement through the wire deployment lumen 132 as shown in FIG. 10 and by the broken lines of FIG. 11 .
- the retention wire 132 and wire lumen 138 can have a circular or rectangular cross-section.
- the retention wire 132 can be formed of a shape memory alloy and possesses superelasticity that enables straightening of the non-straight configuration within the wire deployment lumen 138 .
- Each of the retention wires 112 and 132 can also be formed of a non-conductive plastic material having shape memory of the non-straight configuration when released and capable of being straightened to traverse a wire deployment lumen.
- the particular embodiments of the guide catheter can be used to guide ablation/mapping EP catheters like catheter 10 of FIGS. 1 and 2 or can be used to access the LA from the RA to introduce any other instrument or material into the LA from outside the patient's body in performance of any suitable medical procedure. It will also be understood that the guide catheters of the present invention can be employed to access the LV from the RV to introduce any other instrument or material into the LV from outside the patient's body in performance of any suitable medical procedure. Moreover, it will be apparent that such a guide catheters of the present invention can be employed to access a right heart chamber from a left heart chamber.
- the retention mechanisms are preferably located along the catheter body to be deployed or self deploy into the heart chamber that the distal segment is introduced into to inhibit retraction when retraction force is applied to the guide catheter proximal end drawing the retention mechanism against the septal wall. It will be understood that the deployment mechanisms can be deployed more proximally to the guide catheter body distal segment to bear against the septal wall when advancement force is applied to the guide catheter proximal end. Slight force can then be applied to hold the catheter in position without advancing the guide catheter further into the accessed heart chamber. Moreover, it would be possible to duplicate the retention mechanism to deploy a retention mechanism on either side of the septum.
- the balloon 78 and port 84 can be located along the catheter body to be expanded in the RA.
- An exemplary balloon of this nature is shown as balloon 78 a (shown dashed).
- duplicate balloon 78 a and port can be located along the catheter body to be expanded in the RA along with balloon 78 and port 84 .
- the tines 98 , 100 can be located along the catheter body to extend outward in the RA and bear against the septal wall.
- a duplicate set of tines can be located along the catheter body to extend outward in the RA along with the depicted tines 98 , 100 (and 98 ', 100 ').
- the wire coil 114 can be deployed from the wire deployment lumen 118 from a lumen distal end opening along the catheter body to extend outward in the RA and bear against the septal wall.
- a duplicate wire coil can be deployed along the catheter body to extend outward in the RA along with the depicted wire coil 114 .
- the bent wire distal section 134 can be deployed from the wire deployment lumen 138 from a lumen distal end opening along the catheter body to extend outward in the RA and bear against the septal wall.
- a duplicate bent wire distal section can be deployed along the catheter body to extend outward in the RA along with the depicted bent wire distal section 134 .
Abstract
A trans-septal guide catheter for providing access through the septum separating a first heart chamber from a second heart chamber that includes an elongated guide catheter body extending between guide catheter proximal and distal ends. A distal segment of the guide catheter is adapted to be inserted through the septum to locate the distal segment of the guide catheter within one of the first heart chamber and the second heart chamber. The catheter body encloses a guide catheter lumen adapted to provide access into the one of the first heart chamber and the second heart chamber through a guide catheter lumen proximal end opening and a guide catheter lumen distal end opening. A retention mechanism engages the septum and maintains the distal segment of the guide catheter extending into the one of the first heart chamber and the second heart chamber
Description
- This application claims the benefit of U.S. Provisional Application No. 60/292,483, FILED May 21, 2001, entitled “TRANS-SEPTAL GUIDE CATHETER WITH RETENTION MECHANISM”, incorporated herein by reference in its entirety.
- The present invention relates generally to trans-septal introducers or guide catheters adapted to introduce an instrument through the septum between a left and right heart chamber, and more particularly, the present invention relates to a trans-septal guide catheter having a retention mechanism for retaining the distal end of the guide catheter within the left heart chamber particularly to enable passage therethrough of an electrophysiology (EP) catheter.
- The heart includes a number of pathways through which electrical signals necessary for normal, electrical and mechanical synchronous function of the upper and lower heart chambers propagate. Tachycardia, that is abnormally rapid rhythms of the heart, are caused by the presence of an arrhythmogenic site or accessory pathway, which bypasses or short circuits the nodal pathways in the heart. Tachycardias may be categorized as ventricular tachycardias (VTs) or supraventricular tachycardias (SVTs). The most common SVT's include atrioventricular nodal reentrant tachycardia (AVNRT), Atrioventricular reentrant tachycardia (AVRT), atrial fibrillation (AF), and atrial flutter (AFI). Reentrant tachycardias originate in the atria and are typically caused by an accessory pathway or inappropriate premature return excitation from the ventricle through the AV node or left sided accessory pathway. Conditions such as AF and AFI involve either premature excitation from focal ectopic sites within the atria or excitations coming through inter-atrial reentry pathways as well as regions of slow conduction within the atria. VT's originate from within the ventricles and have their entire circuit contained within the ventricles. These VT's include bundle branch reentrant tachycardia (BBR), right ventricular outflow tract tachycardia (RVOT), and ventricular fibrillation (VF). VT's are often caused by arrhythmogenic sites associated with a prior myocardial infarction as well as reentrant pathways between the ventricles. BBR involves an inappropriate conduction circuit that uses the right and left bundle branches. RVOT can be described as a tachycardia originating from the right ventricular outflow tract, which involves ectopic triggering or reentry mechanisms. VF is a life threatening condition where the ventricles entertain a continuous uncoordinated series of contractions that cause a cessation of blood flow from the heart. If normal sinus rhythm is not restored, the condition is terminal.
- Treatment of both SVTs and VTs may be accomplished by a variety of approaches, including drugs, surgery, implantable electrical stimulators, and catheter ablation of cardiac tissue of an effected pathway. While drugs may be the treatment of choice for many patients, drugs typically only mask the symptoms and do not cure the underlying cause. Implantable electrical stimulators, e.g., pacemakers, afferent nerve stimulators and cardioverter/defibrillators, which have proven to provide successful treatment, usually can only correct an arrhythmia after it occurs and is successfully detected. Surgical and catheter-based treatments, in contrast, will actually cure the problem usually by ablating the abnormal arrhythmogenic tissue or accessory pathway responsible for the tachycardia. The catheter-based treatments rely on the application of various destructive energy sources to the target tissue including direct current electrical energy, radio frequency (RF) electrical energy, laser energy, ultrasound, microwaves, and the like.
- RF ablation protocols have proven to be highly effective in treatment of many cardiac arrhythmias while exposing the patient to minimum side effects and risks. RF catheter ablation is generally performed after an initial electrophysiologic (EP) mapping procedure is conducted using an EP mapping catheter to locate the arrhythmogenic sites and accessory pathways. After EP mapping is completed, an RF ablation catheter having a suitable electrode is introduced to the appropriate heart chamber and manipulated so that the electrode lies proximate the target tissue. Such catheters designed for mapping and ablation, frequently include one or more cylindrical or band-shaped individual electrodes mounted to the distal section of the catheter so as to facilitate mapping of a wider area in less time, or to improve access to target sites for ablation. RF energy is then applied through the electrode(s) to the cardiac tissue to ablate a region of the tissue that forms part of the arrhythmogenic site or the accessory pathway.
- Such mapping and ablation catheters are inserted into a major vein or artery, usually in the neck or groin area, and guided into the chambers of the heart by appropriate manipulation through a venous or arterial route, respectively. The catheter must have a great deal of flexibility or steerability to be advanced through the vascular system into a chamber of the heart, and the catheter must permit user manipulation of the tip even when the catheter body traverses a curved and twisted vascular access pathway. Such catheters must facilitate manipulation of the distal tip so that the distal electrode(s) can be positioned and held against the tissue region to be mapped or ablated.
- The arrhythmogenic sites or accessory pathways to be mapped and ablated frequently occur within the left atrial wall, particularly around pulmonary vein orifices. It is preferable in such cases to introduce an instrument into the right atrium by a venous route including the inferior vena cava and to advance it through the septum separating the right and left atrium. In one exemplary approach, a guide catheter is inserted in this manner into the right atrium, and instruments are introduced through the guide catheter lumen that are manipulated from their proximal end and advanced through the septal wall first creating a very small trans-septal perforation, and then enlarging the perforation by dilation or the like. The guide catheter is then advanced over the instruments or advanced directly through the perforation in the septal wall to locate the guide catheter distal end within the left atrial chamber. The penetrating instruments are retracted from the guide catheter lumen. The proximal end of the guide catheter is typically taped to the patient's body or a support to inhibit retraction back into the right atrial chamber. The mapping and ablation catheters are then inserted through the guide catheter lumen to locate their distal segments within the left atrial chamber.
- The mapping and ablation procedures are undertaken, the mapping and ablation catheters are retracted, and the guide catheter is also retracted. The trans-septal perforation tends to shrink as the dilated myocardial tissue expands across the perforation.
- It is important that the distal segment of the guide catheter inserted through the septum remain in place for the entire procedure and not slip back into the right atrium. The guide catheter can be inadvertently dislodged by movements of the proximal segment emerging from the site of incision. The dislodgement can require withdrawal of the instruments in use, jeopardizing their sterility, while delay occurs in reestablishing catheter position and resumption of the procedure.
- In addition, the only way to monitor the location of the distal segment of the guide catheter is through visualization of a radiopaque marker of the guide catheter in regard to recognizable physiologic features of the heart.
- It is sometimes necessary that the distal end segment of the electrophysiology catheter be directed at an acute angle just as it exits the guide catheter lumen to be directed toward certain features of the left atrium. Therefore, only a very short distal segment of the guide catheter is extended into the left atrium past the septum so that the electrophysiology catheter can be directed to the feature of interest. It is more difficult to maintain the distal segment within the left atrium as the distal segment within the left atrium is shortened.
- There is therefore a need for a guide catheter that does not readily retract through the septum once it has been extended through the septum.
- The present invention is directed to an improved trans-septal guide catheter that can be passed through a septum from one heart chamber to another heart chamber and that possesses a retention mechanism for maintaining a distal segment thereof in the other heart chamber. For example, the trans-septal guide catheter can be introduced into the right atrium, passed through the atrial septum into the left atrium to locate a distal segment thereof within the left atrium, and retained within the left atrium so that the distal segment does not readily retract through the septum into the right atrium.
- The trans-septal guide catheter provides access through the septum separating a right heart chamber from a left heart chamber and preferably includes an elongated guide catheter body extending between guide catheter proximal and distal ends enclosing a guide catheter lumen adapted to provide access into the left heart chamber through a guide catheter lumen proximal end opening and a guide catheter lumen distal end opening. Retention mechanisms are provided for engaging the septum and inhibiting retraction through the septum of the distal segment of the guide catheter extending into the left heart chamber. The trans-septal guide catheter particularly enables passage of an EP catheter through the guide catheter lumen for use in mapping and/or ablation of accessory pathways in myocardial tissue of the left atrial heart wall.
- In one embodiment, the retention mechanism further includes at least one flexible, pliant, tine extending outwardly from a tine attachment with the distal segment of the guide catheter body to a tine free end. The tine free end is adapted to deflect inward toward the guide catheter body when restrained during advancement of the guide catheter and to extend further outward from the guide catheter body when restrained against the septal wall when any retraction force is applied to the guide catheter tending to retract the distal segment of the guide catheter body back into the right heart chamber.
- In another embodiment, the retention mechanism includes an inflatable balloon inflated and deflated through an inflation and deflation lumen within the guide catheter body extending from a proximal inflation port at the guide catheter proximal end to a balloon inflation port within the inflatable balloon. The inflation medium is introduced through the balloon inflation and deflation lumen to inflate the balloon after the balloon is advanced through the septum into the left heart chamber. The inflated balloon bears against the septal wall and inhibits retraction through the septum of the distal segment of the guide catheter extending into the left heart chamber.
- In still another embodiment, the retention mechanism includes a wire that is extendable through a wire deployment lumen of the catheter body. A distal wire segment has a non-straight configuration when extended out of the deployment lumen end opening and into engagement with the septal wall of the septum within the left heart chamber that inhibits retraction through the septum of the distal segment of the guide catheter extending into the left heart chamber and is straightened when advanced through the wire deployment lumen.
- The non-straight configuration of the retention wire can include a wire coil formed of a plurality of wire turns of a coil, e.g., a planar coil, or an acute bend in the wire. The retention wire can be formed of a shape memory alloy to possess superelasticity that enables straightening of the non-straight configuration within the wire deployment lumen.
- The guide catheters of the present invention solve the problem of maintaining the distal segment thereof in the heart chamber that the distal segment is introduced into and enables shortening of the length of the distal segment to enable maximal access to features of the heart chamber, particularly the left atrium. The retention mechanisms ensure that vent ports in the sidewall of the guide catheter body distal segment are within the heart chamber that the distal segment is introduced into and are not obstructed by the septum.
- The retention mechanisms are preferably located to be deployed or self deploy in the heart chamber that the distal segment is introduced into to inhibit retraction when retraction force is applied to the guide catheter proximal end drawing the retention mechanism against the septal wall. It will be understood that the deployment mechanisms can be deployed more proximally to the guide catheter body distal segment to bear against the septal wall when advancement force is applied to the guide catheter proximal end. Slight force can then be applied to hold the catheter in position without advancing the guide catheter further into the accessed heart chamber. Moreover, it would be possible to duplicate the retention mechanism to deploy a retention mechanism on either side of the septum.
- This summary of the invention and the advantages and features thereof have been presented here simply to point out some of the ways that the invention overcomes difficulties presented in the prior art and to distinguish the invention from the prior art and is not intended to operate in any manner as a limitation on the interpretation of claims that are presented initially in the patent application and that are ultimately granted.
- These and other features and advantages of the invention will become apparent from the following description in which the preferred embodiments are disclosed in detail in conjunction with the accompanying drawings in which:
-
FIG. 1 is an overall view of one embodiment of an ablation and/or EP mapping catheter that can be passed through a guide catheter of the present invention; -
FIG. 2 is a schematic illustration of the introduction of the ablation and/or EP mapping catheter distal section into the left atrium through the lumen of a guide catheter extending through an incision or perforation through the septum between the right and left atrium; -
FIG. 3 is a simplified schematic illustration of a first embodiment of a guide catheter of the present invention having a deployable retention mechanism comprising an expandable balloon expanded in the left atrium and drawn against the septal wall in the left atrium to inhibit retraction of the guide catheter distal segment into the right atrium; -
FIG. 4 is a cross-section view along lines 4-4 ofFIG. 3 depicting the guide catheter lumen and balloon inflation/deflation lumen; -
FIG. 5 is a simplified schematic illustration of a second embodiment of a guide catheter of the present invention having a retention mechanism comprising a plurality of pliant tines drawn against the septal wall in the left atrium to inhibit retraction of the guide catheter distal segment into the right atrium; -
FIG. 6 is an end view of the distal segment of the guide catheter ofFIG. 5 depicting the guide catheter lumen and outwardly extending tines; -
FIG. 7 is a simplified schematic illustration of a third embodiment of a guide catheter of the present invention having a deployable retention mechanism comprising an extendable wire that forms a wire coil when extended from a wire deployment lumen into the left atrium and inhibits retraction of the guide catheter distal segment into the right atrium; -
FIG. 8 is a simplified schematic illustration of the third embodiment of a guide catheter of the present invention showing the extendable wire that forms the wire coil when extended into the left atrium retracted into the wire deployment lumen during introduction or withdrawal of the distal segment through the septum into or from the left atrium; -
FIG. 9 is a simplified schematic illustration of a fourth embodiment of a guide catheter of the present invention having a deployable retention mechanism comprising an extendable wire that bends over at an acute angle when extended from a wire lumen into the left atrium and inhibits retraction of the guide catheter distal segment into the right atrium; -
FIG. 10 is a simplified schematic illustration of the fourth embodiment of a guide catheter of the present invention showing the extendable wire that bends over when extended into the left atrium retracted into the wire deployment lumen during introduction or withdrawal of the distal segment through the septum into or from the left atrium; - FIG.11 is an expanded view of the distal end segment of the extendable wire of
FIGS. 9 and 10 ; and -
FIG. 12 is a cross-section view along lines 12-12 ofFIGS. 7-10 depicting the guide catheter lumen and one embodiment of the extendable wire lumen and extendable wire cross-section. -
FIG. 1 schematically illustrates an anatomically-conforming, multi-curve ablation and/orEP mapping catheter 10 that can be introduced through a guide catheter of the present invention for orienting a distal tip electrode 12 (or electrodes) with respect to the heart wall for RF ablation and/or EP mapping. Themulti-curve catheter 10 can incorporate a porous tip and catheter lumen for emitting irrigating fluid around thedistal tip electrode 12, but those features are not illustrated inFIG. 1 to simplify illustration. Moreover, thedistal segment 32 is simplified inFIG. 1 to show an elongated tubular shapedablation electrode 12 and a pair ofmapping electrodes FIG. 1 , but thedistal segment 32 may include a plurality of ring-shaped electrodes, one or more coil electrode or the like having other shapes that are presently used or may come into use and including several variations described below in reference to other figures including visible or invisible light, infrared, and electrical energy from or along the distal tip. - The
catheter 10 includes a catheter shaft orbody 20 and a handle 40. The catheter shaft orbody 20 has ashaft axis 24 and extends between adistal end 26 and aproximal end 28 and is separated into aproximal section 22 and a distal section 30.Catheter body 20 may be of any suitable diameter and length and may be straight or pre-curved along its length, but preferably is straight when unrestrained. The distal section 30 or the distal segment thereof can be tapered from the diameter of theproximal section 22. Preferably, thecatheter body 20 has a uniform outside diameter of about 0.052 inch (1.32 mm) to 0.1040 inch (2.64 mm) and a length of about 50 cm to 110 cm. - The
proximal section 22 has sufficient column strength and is capable of good torque transmission to permit controlled placement of the distal section 30 at a target site in the heart including a selected cardiac valve or vessel in the manners discussed below. The distal section 30 is deflectable away fromshaft axis 24 and includes adistal segment 32, a curvableproximal segment 36 having a proximal segment length, and a bendableintermediate segment 34 having an intermediate segment length disposed between thedistal segment 32 and the curvableproximal segment 36. Theillustrative tip electrode 12 is positioned along thedistal segment 32, preferably extending proximally from the catheter bodydistal end 26 through all or part of the length of thedistal segment 32. Thedistal segment 32 can include anelongated ablation electrode 12 that may be solid or irrigated and can include one or moreproximal ring electrodes ablation electrode 12. Each electrode is separately connected to insulated conductors extending proximally through thecatheter body 20 to terminals of a cable connector in or on the handle 40 that is connected via a cable to the ablation energy source and/or mapping signal amplifiers. As described further below, a thermocouple is also typically included in thedistal segment 32 of such ablation catheters, and separately insulated thermocouple conductors extending proximally through thecatheter body 20 to terminals of the cable connector in or on the handle 40 that are coupled via a cable to the temperature display and ablation energy control apparatus known in the art. - The handle 40 can take any of the forms known in the art for making electrical connections with the conductors within the
catheter body 20, for delivering irrigation fluid to an irrigation lumen (if present) of thecatheter body 20. The handle 40 also includes a mechanism for deflecting the distal tip section 30 into the shapes provided by the present invention. The mechanism can take any form for pulling, pushing and/or twisting the deflection or push/pull wires within thecatheter body 20 as described further below. In the illustrated embodiment, the handle 40 is attached to the catheter bodyproximal end 28 and supports axially slidable manipulators comprising push-pull rings 44 and 46 and a rotatablelateral deflection ring 42 that are coupled to the proximal ends of a curve deflection push-pull wire, a knuckle deflection push-pull wire, and a lateral deflection wire identified and described further below. Thelateral deflection ring 42 can be rotated to impart a torque in a lateral deflection wire coupled thereto to laterally rotate the distal section 30 with respect toaxis 24 within theproximal section 22. - As shown in
FIG. 1 , when the push-pull wires are relaxed, thedistal segment 32, the bendableintermediate segment 34, and the curvableproximal segment 36 are aligned with theshaft axis 24 that is referenced as 0°. The knuckle deflection push-pull wire can be retracted or pulled by slidingring 46 proximally to impart a small radius bend from substantially 0°, wherein the distal andproximal segments proximal segments pull ring 46 distally to impart a small radius bend from substantially 0° to about −90°, that is in a bend direction opposite to the bend direction imparted when the knuckle deflection push-pull wire is retracted or pulled by slidingring 46 proximally. Theintermediate segment 34 is bent in a bending radius of between 2.0 mm and 7.0 mm, and preferably less than about 5.0 mm within the bending angle range. The abrupt knuckle bend angle range can be restricted further by positioning of the slide end stops for the push-pull ring 46 during assembly. - The manipulator push-
pull ring 44 can be moved proximally or distally to move the curve deflection push-pull wire coupled thereto proximally or distally to form a curve in theproximal segment 36 that is opposed to or in the same direction as the bend imparted in theintermediate segment 34. The bend or curve of theproximal segment 36 that can be induced relative to thecatheter body axis 24 as depicted in the figures can be between −90° to +270° relative to theproximal section 22. The curvature range of theproximal segment 36 can be restricted further by position of the slide end stops for the push-pull ring 44 during assembly. - Many possible co-planar curves induced in the segments of the distal section 30 in relation to the
catheter body axis 24 accomplished by selective movement of the axially slidable manipulator rings 46 and 44 coupled to the knuckle deflection push-pull wire 56 and the curve deflection push-pull wire 54, respectively. The distal end of the knuckle deflection push-pull wire 56 terminates at the junction of theintermediate segment 34 with thedistal segment 32, and the curve deflection push-pull wire 54 terminates at the junction of theintermediate segment 34 with theproximal segment 36. The knuckle deflection push-pull wire 56 and the curve deflection push-pull wire 54 extend in parallel with and are radially aligned to thecatheter body axis 24 along a common radius extending from thecatheter body axis 24 through theproximal section 22 and theproximal segment 36. The knuckle deflection push-pull wire 56 is spaced further away from theaxis 24 than the curve deflection push-pull wire 54 through theproximal section 22 andproximal segment 36. The distal section of the knuckle deflection push-pull wire 56 traversing theintermediate segment 34 is axially aligned with the axis of the curve deflection push-pull wire 54 in theproximal segment 36. - When the
ring 42 is rotated clockwise or counterclockwise, the lateral deflection wire is twisted, causing the junction of the proximal andintermediate segments tip segment 32 and theintermediate segment 34 in the range of −90° to +90° with respect to catheter bodystraight axis 24 can be achieved by such rotation. - The structure of the
catheter body 20 that achieves these angular tip section deflections and the lateral deflection is illustrated in commonly assigned U.S. patent application Ser. No. (P-9288.00), filed Oct. 10, 2000, in the names of Mark T. Stewart et al. for HEART WALL ABLATION/MAPPING CATHETER AND METHOD. The guide catheter of the present invention is advantageously employed with this and other ablation and/or EP mapping catheters that are introduced into through the guide catheter lumen that is itself extended from the right atrium through the septum to locate a distal segment of the guide catheter therein as shown inFIG. 2 , for example. -
FIG. 2 is a schematic illustration of the introduction of the ablation and/or EP mapping catheter distal section into the left atrium through thelumen 64 of a guide sheath or catheter 60 extending through an incision or perforation through the septum to locate a guide catheterdistal segment 62 within the left atrium.FIG. 2 illustrates, in simplified form, a sectionedheart 100 and the major vessels bringing venous blood into the right atrium RA, oxygenated blood into the left atrium (LA) and the aorta and aortic arch (FIG. 20 ) receiving oxygenated blood from the left ventricle (LV). The venous blood is delivered to the RA through the superior vena cava (SVC), the inferior vena cava (IVC) and the coronary sinus (CS) which all open into the right atrium (RA) superior to the annulus of the tricuspid valve leading into the right ventricle. Oxygenated blood from the two lungs is delivered into the left atrium by the left and right, inferior and superior, pulmonary veins (LIPV, LSPV, RIPV and RSPV) which are superior to the mitral valve. The RA and LA are separated by aninter-atrial septum 68, and the RV and LV are separated by a ventricular septum. The tricuspid valve and mitral valve are not shown completely to simplify the figures. - Accessory pathways develop in several parts of the RA and LA that are reached by the
catheter 10 to be mapped and/or ablated in accordance with methods of use thereof. Premature activations that cause atrial fibrillation occur frequently in the LA wall, particularly from pulmonary venous foci around the annular orifices of certain or all of the pulmonary veins RIPV, RSPV, LIPV, LSPV shown inFIG. 2 . The LA can be accessed in a retrograde manner through the aorta. However, another convenient approach to the LA is via a puncture or perforation made through the inter-atrial septum from the RA. The transseptal guide sheath or catheter 60 depicted inFIG. 2 is inserted through theseptum 68 via theperforation 66. - The EP mapping/
ablation catheter 20 is introduced through theguide catheter lumen 64, and the handle is manipulated to form the distal section 30 with about a +90° knuckle bend made in the intermediate segment and slight positive, neutral or negative curvatures in the range of about −45° to +45° in theproximal segment 36 to align the distal tip tolocations - These manipulations can require that the length of the guide catheter
distal segment 62 be minimized and can cause inadvertent retraction of thedistal segment 62 through theperforation 66 in theseptal wall 68 and into the RA. The guide catheters of the present invention are formed with a retention mechanism that is deployed to bear against the LA wall around or alongside theperforation 66. Theperforation 66 is first formed through the septal wall of theseptum 68, a distal segment of the guide catheter is advanced into the right heart chamber. In this particular case, the guide catheter is advanced through the IVC into the RA and then through theperforation 66 to locate the distal segment in the LA. Then, the retention mechanism is deployed or self deploys into engagement with theseptum 68 to inhibit retraction of the distal segment of the guide catheter through theperforation 66 back into RA when any retraction force is applied to the guide catheter. In this way, access is provided to introduce instruments or materials into the LA. The preferred use of the guide catheter of the present invention is to introduce a mapping/ablation EP catheter of the type depicted in FIGs.1 and 2, for example, into the LA. Then, the deployment mechanism is withdrawn or retracted or overcome by applied retraction force to enable withdrawal of the guide catheter through theperforation 66. -
FIG. 3 is a simplified schematic illustration of a first embodiment of aguide catheter 70 of the present invention having a deployable retention mechanism comprising anexpandable balloon 78 expanded in the LA and drawn against the septal wall in the LA of theseptum 66 to inhibit retraction of the guide catheterdistal segment 76 into the RA.FIG. 4 is a cross-section view along lines 4-4 ofFIG. 3 depicting theguide catheter lumen 72 and balloon inflation/deflation lumen 82 within theguide catheter body 80. - The
inflatable balloon 78 is inflated and deflated through the inflation/deflation lumen 82 that extends within theguide catheter body 80 from aproximal inflation port 86 at the guide catheterproximal end 74 to aballoon inflation port 84 within theinflatable balloon 78. The inflation medium (preferably a fluid, e.g., saline or a radiopaque solution) is introduced through the balloon inflation/deflation lumen 82 to inflate theballoon 78 after the deflatedballoon 78 is advanced through theseptum 68 into the LA. Theinflated balloon 78 bears against the septal wall and resists or inhibits retraction through theseptum 66 of thedistal segment 76 of theguide catheter 70 extending into the LA. The mapping/ablation EP catheter can then be introduced through theguide catheter lumen 72 as depicted inFIG. 2 to map or ablate cardiac tissue. - It may be noted that
guide catheter 70 may include a second expandable balloon 78 a (shown dashed) that is adapted to be expanded in the RA and drawn against the septal wall. This is discussed further below. -
FIG. 5 illustrates a second embodiment of a guide catheter 90 of the present invention having a self deployed retention mechanism that includes a plurality ofpliant tines distal segment 96 through theperforation 66 into the RA.FIG. 6 is an end view of thedistal segment 96 of the guide catheter ofFIG. 5 depicting the guide catheter lumen 92 and outwardly extendingtines - Each such flexible, pliant,
tine tine attachment free end tines respective tine attachments guide catheter body 94 at an acute angle to theguide catheter body 94. Thetines tines - The tine free ends 106 and 108 are able to deflect inward toward the
guide catheter body 94 by contact against theseptum 68 when the guide catheter 90 is advanced through theperforation 66. Thetines guide catheter body 94 against the septal wall as shown inFIG. 5 when any retraction force is applied to the guide catheter 90 tending to retract thedistal segment 96 of the guide catheter body back into the RA. While thetines guide catheter body 94 at its proximal end in order to retract thedistal segment 96 through theperforation 66. - It will be understood that more than one tine can be employed arrayed around the circumference of the
catheter body 94. Two additional tines 98' and 100' are illustrated in broken lines inFIG. 6 to illustrate four tines in this instance. The additional tines 98', 100' are formed and function in the same manner astines -
FIG. 7 illustrates a third embodiment of aguide catheter 110 of the present invention having a deployable retention mechanism that includes anextendable wire 112 that forms awire coil 114 when extended from a wire deployment lumen 118 (shown inFIG. 12 ) into the LA and inhibits retraction of the guide catheter distal segment 116 into the RA. The catheter body 122 encloses a guide catheter lumen 124 (FIG. 12 ) adapted to receive a mapping/ablation EP catheter and thewire deployment lumen 118 extending between a deployment lumen proximal end opening and a deployment lumen distal end opening in thedistal segment 120.FIG. 8 shows theextendable wire 112 that forms awire coil 114 when extended into the LA retracted into thewire lumen 118 during introduction into or withdrawal from the RA of the distal segment 116 through theperforation 66 in theseptum 68. - In use, the
elongated retention wire 112 is extended at guide catheterproximal end 126 through thewire deployment lumen 118 to dispose thedistal wire segment 114 within the LA as shown inFIG. 7 . Thedistal wire segment 114 is straightened when advanced through thewire deployment lumen 118 but forms a non-straight configuration when extended out of the deployment lumen end opening and into engagement with the septal wall of theseptum 68 within the LA that inhibits retraction through the septum of thedistal segment 120 extending into the LA. The mapping/ablation EP catheter can then be introduced through theguide catheter lumen 124 as depicted inFIG. 2 to map or ablate cardiac tissue. When the procedure is completed, theelongated retention wire 112 is retracted as shown inFIG. 8 to enable retraction of the guide catheterdistal segment 120 back into the RA. - The
retention wire 112 andwire lumen 118 can have a circular or rectangular cross-section, and thewire coil 114 can be any desired non-straight configuration, e.g., a wire coil formed of a plurality of wire turns wound in a common plane as shown or into any other coil shape. Theretention wire 112 can be formed of a shape memory alloy that possesses superelasticity that enables straightening of the non-straight configuration within thewire deployment lumen 118. -
FIGS. 9-11 illustrate a fourth embodiment of aguide catheter 130 of the present invention having a deployable retention mechanism that includes adistal section 134 ofextendable wire 132. Thedistal section 134 bends over at an acute angle at bend 146 when extended from a wire lumen 138 (FIG. 12 ) into the LA and inhibits retraction of the guide catheterdistal segment 140 into the RA by bearing against the septal wall ofseptum 68. The acute bend 146 in thewire 132 is straightened during advancement through thewire deployment lumen 132 as shown inFIG. 10 and by the broken lines ofFIG. 11 . - The
retention wire 132 andwire lumen 138 can have a circular or rectangular cross-section. Theretention wire 132 can be formed of a shape memory alloy and possesses superelasticity that enables straightening of the non-straight configuration within thewire deployment lumen 138. - Each of the
retention wires - It will be seen that the particular embodiments of the guide catheter can be used to guide ablation/mapping EP catheters like
catheter 10 ofFIGS. 1 and 2 or can be used to access the LA from the RA to introduce any other instrument or material into the LA from outside the patient's body in performance of any suitable medical procedure. It will also be understood that the guide catheters of the present invention can be employed to access the LV from the RV to introduce any other instrument or material into the LV from outside the patient's body in performance of any suitable medical procedure. Moreover, it will be apparent that such a guide catheters of the present invention can be employed to access a right heart chamber from a left heart chamber. - Each of the above-described embodiments and alternatives and equivalents thereof are used in a method of providing access through the septum separating a right heart chamber from a left heart chamber and deploying the retention mechanism into engagement with the septum to maintain the distal segment of the guide catheter extending into the heart chamber accessed by the perforation in place. The retention mechanisms are preferably located along the catheter body to be deployed or self deploy into the heart chamber that the distal segment is introduced into to inhibit retraction when retraction force is applied to the guide catheter proximal end drawing the retention mechanism against the septal wall. It will be understood that the deployment mechanisms can be deployed more proximally to the guide catheter body distal segment to bear against the septal wall when advancement force is applied to the guide catheter proximal end. Slight force can then be applied to hold the catheter in position without advancing the guide catheter further into the accessed heart chamber. Moreover, it would be possible to duplicate the retention mechanism to deploy a retention mechanism on either side of the septum.
- For example, referring back to
FIG. 3 , theballoon 78 andport 84 can be located along the catheter body to be expanded in the RA. An exemplary balloon of this nature is shown as balloon 78 a (shown dashed). In one embodiment, duplicate balloon 78 a and port can be located along the catheter body to be expanded in the RA along withballoon 78 andport 84. Referring to FlGs. 5 and 6, thetines 98,100 (and 98', 100') can be located along the catheter body to extend outward in the RA and bear against the septal wall. Or, a duplicate set of tines can be located along the catheter body to extend outward in the RA along with the depictedtines 98,100 (and 98', 100'). Referring toFIG. 8 , thewire coil 114 can be deployed from thewire deployment lumen 118 from a lumen distal end opening along the catheter body to extend outward in the RA and bear against the septal wall. Or, a duplicate wire coil can be deployed along the catheter body to extend outward in the RA along with the depictedwire coil 114. Referring toFIG. 9 , the bent wiredistal section 134 can be deployed from thewire deployment lumen 138 from a lumen distal end opening along the catheter body to extend outward in the RA and bear against the septal wall. Or, a duplicate bent wire distal section can be deployed along the catheter body to extend outward in the RA along with the depicted bent wiredistal section 134. - Although particular embodiments of the invention have been described herein in some detail, this has been done for the purpose of providing a written description of the invention in an enabling manner and to form a basis for establishing equivalents to structure and method steps not specifically described or listed. It is contemplated by the inventors that the scope of the limitations of the following claims encompasses the described embodiments and equivalents thereto now known and coming into existence during the term of the patent. Thus, it is expected that various changes, alterations, or modifications may be made to the invention as described herein without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (50)
1-28. (canceled)
29. An ablation system comprising:
a trans-septal guide catheter for providing access through the septum separating a first heart chamber from a second heart chamber comprising an elongated guide catheter body extending between guide catheter proximal and distal ends, a distal segment of the guide catheter adapted to be inserted through the septum to locate the distal segment of the guide catheter within one of the first heart chamber and the second heart chamber, the catheter body enclosing a guide catheter lumen adapted to provide access into the one of the first heart chamber and the second heart chamber through a guide catheter lumen proximal end opening and a guide catheter lumen distal end opening, the catheter body enclosing first and second inflation and deflation lumens fluidly connected to first and second proximal inflation ports and first and second distal inflatable balloons, the first and second balloons adapted to engage the septum.
30. The system of claim 29 wherein an inflation medium is introduced through the first balloon inflation and deflation lumen to inflate the first balloon.
31. The system of claim 29 wherein the first balloon is adapted to be inflated in one of the first heart chamber and the second heart chamber.
32. The system of claim 29 wherein an inflation medium is introduced through the second balloon inflation and deflation lumen to inflate the second balloon.
33. The system of claim 29 wherein the second balloon is adapted to be inflated in one of the first heart chamber and the second heart chamber.
34. The system of claim 29 wherein the first and second balloons are adapted to be inflated on opposite sides of the septum.
35. The system of claim 34 wherein the first balloon is inflated in the right atrial chamber and the second balloon is inflated in the left atrial chamber.
36. The system of claim 29 wherein the trans-septal guide catheter is adapted to be advanced through an opening in the septum.
37. The system of claim 36 wherein the opening is a formed via a puncture.
38. The system of claim 36 wherein the opening is a formed via a perforation.
39. The system of claim 29 wherein the first heart chamber is an atrial chamber.
40. The system of claim 39 wherein the atrium is a right atrial chamber.
41. The system of claim 39 wherein the atrium is a left atrial chamber.
42. The system of claim 29 wherein the second heart chamber is an atrial chamber.
43. The system of claim 42 wherein the atrium is a right atrial chamber.
44. The system of claim 42 wherein the atrium is a left atrial chamber.
45. The system of claim 29 further comprising an ablation device for delivering ablating energy to tissue, the ablation device being adapted to be positioned through the guide catheter lumen, the ablation device comprising an ablation energy source and an ablation catheter having an ablation member coupled to the ablation energy source.
46. The system of claim 45 wherein the ablation member is an ablation electrode.
47. The system of claim 46 wherein the ablation electrode is a tubular shaped electrode.
48. The system of claim 46 wherein the ablation electrode is a ring-shaped shaped electrode.
49. The system of claim 46 wherein the ablation electrode is a coil electrode.
50. The system of claim 45 wherein the ablating energy is direct current electrical energy.
51. The system of claim 45 wherein the ablating energy is radio frequency electrical energy.
52. The system of claim 45 wherein the ablating energy is laser energy.
53. The system of claim 45 wherein the ablating energy is ultrasound energy.
54. The system of claim 45 wherein the ablating energy is microwave energy.
55. An ablation method comprising:
inserting a distal end of a trans-septal catheter device into a patient;
advancing the distal end through the patient into a first heart chamber;
advancing the distal end through the septum separating the first heart chamber from a second heart chamber;
inflating a first distal balloon of the catheter device to engage the septum;
inflating a second distal balloon of the catheter device to engage the septum;
advancing an ablation member through the septum and into the second heart chamber;
positioning the ablation member proximate heart tissue to be ablated; and
delivering ablating energy from an ablation energy source to the ablation member to ablate heart tissue proximate the ablation member.
56. The method of claim 55 wherein the trans-septal catheter device comprises:
an elongated catheter body extending between catheter proximal and distal ends, a distal segment of the catheter adapted to be inserted through the septum to locate the distal end of the catheter within the second heart chamber, the catheter body enclosing a catheter lumen adapted to provide access into the second heart chamber through a catheter lumen proximal end opening and a catheter lumen distal end opening, the catheter body enclosing first and second inflation and deflation lumens fluidly connected to first and second proximal inflation ports and first and second distal balloons, the first and second balloons adapted to engage the septum.
57. The method of claim 56 wherein the ablation member is advanced through the catheter lumen.
58. The method of claim 55 wherein the distal end of the catheter is inserted into the neck or groin area of the patient.
59. The method of claim 55 wherein the distal end of the catheter is inserted into a major artery or vein.
60. The method of claim 55 wherein the first heart chamber is a right atrial chamber and the second heart chamber is a left atrial chamber.
61. The method of claim 55 wherein the first heart chamber is a left atrial chamber and the second heart chamber is a right atrial chamber.
62. The method of claim 55 wherein the ablation member is an ablation electrode.
63. The method of claim 62 wherein the ablation electrode is a tubular shaped electrode.
64. The method of claim 62 wherein the ablation electrode is a ring-shaped shaped electrode.
65. The method of claim 62 wherein the ablation electrode is a coil electrode.
66. The method of claim 55 wherein the ablating energy is direct current electrical energy.
67. The method of claim 55 wherein the ablating energy is radio frequency electrical energy.
68. The method of claim 55 wherein the ablating energy is laser energy.
69. The method of claim 55 wherein the ablating energy is ultrasound energy.
70. The method of claim 55 wherein the ablating energy is microwave energy.
71. The method of claim 55 wherein the heart tissue to be ablated is myocardial tissue.
72. The method of claim 55 wherein the distal end of the catheter is advanced through an opening in the septum.
73. The method of claim 72 wherein the opening is formed via a puncture.
74. The method of claim 72 wherein the opening is formed via a perforation.
75. The method of claim 55 wherein the ablation lesions are made around an orifice.
76. The method of claim 55 further comprising inflating the first and second balloons on opposite sides of the septum.
77. The method of claim 55 further comprising delivering an irrigating fluid around the ablation member while delivering ablating energy to the ablation member.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/399,865 US20060184221A1 (en) | 2001-05-21 | 2006-04-07 | Trans-septal catheter with retention mechanism |
US13/343,815 US20120101434A1 (en) | 2001-05-21 | 2012-01-05 | Trans-septal catheter with retention mechanism |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29248301P | 2001-05-21 | 2001-05-21 | |
US10/152,553 US20030130713A1 (en) | 2001-05-21 | 2002-05-21 | Trans-septal catheter with retention mechanism |
US11/399,865 US20060184221A1 (en) | 2001-05-21 | 2006-04-07 | Trans-septal catheter with retention mechanism |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/152,553 Continuation US20030130713A1 (en) | 2001-05-21 | 2002-05-21 | Trans-septal catheter with retention mechanism |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/923,320 Division US8096959B2 (en) | 2001-05-21 | 2007-10-24 | Trans-septal catheter with retention mechanism |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060184221A1 true US20060184221A1 (en) | 2006-08-17 |
Family
ID=23124867
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/152,553 Abandoned US20030130713A1 (en) | 2001-05-21 | 2002-05-21 | Trans-septal catheter with retention mechanism |
US11/399,865 Abandoned US20060184221A1 (en) | 2001-05-21 | 2006-04-07 | Trans-septal catheter with retention mechanism |
US11/923,320 Expired - Fee Related US8096959B2 (en) | 2001-05-21 | 2007-10-24 | Trans-septal catheter with retention mechanism |
US13/343,815 Abandoned US20120101434A1 (en) | 2001-05-21 | 2012-01-05 | Trans-septal catheter with retention mechanism |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/152,553 Abandoned US20030130713A1 (en) | 2001-05-21 | 2002-05-21 | Trans-septal catheter with retention mechanism |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/923,320 Expired - Fee Related US8096959B2 (en) | 2001-05-21 | 2007-10-24 | Trans-septal catheter with retention mechanism |
US13/343,815 Abandoned US20120101434A1 (en) | 2001-05-21 | 2012-01-05 | Trans-septal catheter with retention mechanism |
Country Status (3)
Country | Link |
---|---|
US (4) | US20030130713A1 (en) |
CA (1) | CA2446920A1 (en) |
WO (1) | WO2002094363A2 (en) |
Cited By (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070038280A1 (en) * | 2005-08-12 | 2007-02-15 | Cardiac Pacemakers, Inc. | Co-radial lead with extendable/retractable fixation mechanism and apparatus therefor |
US20090198297A1 (en) * | 2004-08-18 | 2009-08-06 | Yongxing Zhang | Transeptal lead |
US8880185B2 (en) | 2010-06-11 | 2014-11-04 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US8926605B2 (en) | 2012-02-07 | 2015-01-06 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for radiometrically measuring temperature during tissue ablation |
US8939970B2 (en) | 2004-09-10 | 2015-01-27 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US8954161B2 (en) | 2012-06-01 | 2015-02-10 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for radiometrically measuring temperature and detecting tissue contact prior to and during tissue ablation |
US8951251B2 (en) | 2011-11-08 | 2015-02-10 | Boston Scientific Scimed, Inc. | Ostial renal nerve ablation |
US8961506B2 (en) | 2012-03-12 | 2015-02-24 | Advanced Cardiac Therapeutics, Inc. | Methods of automatically regulating operation of ablation members based on determined temperatures |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9028472B2 (en) | 2011-12-23 | 2015-05-12 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9125666B2 (en) | 2003-09-12 | 2015-09-08 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US9125667B2 (en) | 2004-09-10 | 2015-09-08 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US9186209B2 (en) | 2011-07-22 | 2015-11-17 | Boston Scientific Scimed, Inc. | Nerve modulation system having helical guide |
US9186210B2 (en) | 2011-10-10 | 2015-11-17 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9277961B2 (en) | 2009-06-12 | 2016-03-08 | Advanced Cardiac Therapeutics, Inc. | Systems and methods of radiometrically determining a hot-spot temperature of tissue being treated |
US9297845B2 (en) | 2013-03-15 | 2016-03-29 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
US9327100B2 (en) | 2008-11-14 | 2016-05-03 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9486355B2 (en) | 2005-05-03 | 2016-11-08 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US9510905B2 (en) | 2014-11-19 | 2016-12-06 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for high-resolution mapping of tissue |
US9517103B2 (en) | 2014-11-19 | 2016-12-13 | Advanced Cardiac Therapeutics, Inc. | Medical instruments with multiple temperature sensors |
US9579030B2 (en) | 2011-07-20 | 2017-02-28 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
US9636173B2 (en) | 2010-10-21 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal neuromodulation |
US9636164B2 (en) | 2015-03-25 | 2017-05-02 | Advanced Cardiac Therapeutics, Inc. | Contact sensing systems and methods |
US9649156B2 (en) | 2010-12-15 | 2017-05-16 | Boston Scientific Scimed, Inc. | Bipolar off-wall electrode device for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9757193B2 (en) | 2002-04-08 | 2017-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Balloon catheter apparatus for renal neuromodulation |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US9808300B2 (en) | 2006-05-02 | 2017-11-07 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9827039B2 (en) | 2013-03-15 | 2017-11-28 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9827040B2 (en) | 2002-04-08 | 2017-11-28 | Medtronic Adrian Luxembourg S.a.r.l. | Methods and apparatus for intravascularly-induced neuromodulation |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
US9907609B2 (en) | 2014-02-04 | 2018-03-06 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US9919144B2 (en) | 2011-04-08 | 2018-03-20 | Medtronic Adrian Luxembourg S.a.r.l. | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US9943365B2 (en) | 2013-06-21 | 2018-04-17 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US9993178B2 (en) | 2016-03-15 | 2018-06-12 | Epix Therapeutics, Inc. | Methods of determining catheter orientation |
US10022182B2 (en) | 2013-06-21 | 2018-07-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US10166069B2 (en) | 2014-01-27 | 2019-01-01 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods |
US10166062B2 (en) | 2014-11-19 | 2019-01-01 | Epix Therapeutics, Inc. | High-resolution mapping of tissue with pacing |
US10188829B2 (en) | 2012-10-22 | 2019-01-29 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US10342609B2 (en) | 2013-07-22 | 2019-07-09 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US10548663B2 (en) | 2013-05-18 | 2020-02-04 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters with shafts for enhanced flexibility and control and associated devices, systems, and methods |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10588682B2 (en) | 2011-04-25 | 2020-03-17 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US10722300B2 (en) | 2013-08-22 | 2020-07-28 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
US10736690B2 (en) | 2014-04-24 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters and associated systems and methods |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US10888373B2 (en) | 2017-04-27 | 2021-01-12 | Epix Therapeutics, Inc. | Contact assessment between an ablation catheter and tissue |
US10945786B2 (en) | 2013-10-18 | 2021-03-16 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8091556B2 (en) | 2001-04-20 | 2012-01-10 | V-Wave Ltd. | Methods and apparatus for reducing localized circulatory system pressure |
US20040230283A1 (en) * | 2001-11-29 | 2004-11-18 | Medtronic, Inc. | Trans-septal pacing method and apparatus |
US6984232B2 (en) * | 2003-01-17 | 2006-01-10 | St. Jude Medical, Daig Division, Inc. | Ablation catheter assembly having a virtual electrode comprising portholes |
US7387629B2 (en) | 2003-01-21 | 2008-06-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter design that facilitates positioning at tissue to be diagnosed or treated |
US6960207B2 (en) * | 2003-01-21 | 2005-11-01 | St Jude Medical, Daig Division, Inc. | Ablation catheter having a virtual electrode comprising portholes and a porous conductor |
US7789877B2 (en) | 2003-07-02 | 2010-09-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter electrode arrangement |
US8021387B2 (en) | 2003-07-11 | 2011-09-20 | Biosense Webster, Inc. | Trans-septal sheath with splitting dilating needle and method for its use |
AU2005211243A1 (en) * | 2004-02-03 | 2005-08-18 | Atria Medical Inc. | Device and method for controlling in-vivo pressure |
DE102005011656A1 (en) * | 2005-03-14 | 2006-09-21 | Breeze Medical, Inc., Boca Raton | System for delivering an agent into a blood vessel |
US9681948B2 (en) | 2006-01-23 | 2017-06-20 | V-Wave Ltd. | Heart anchor device |
EP3329860A1 (en) | 2006-11-07 | 2018-06-06 | David Stephen Celermajer | Devices for the treatment of heart failure |
US9232997B2 (en) | 2006-11-07 | 2016-01-12 | Corvia Medical, Inc. | Devices and methods for retrievable intra-atrial implants |
US8882697B2 (en) * | 2006-11-07 | 2014-11-11 | Dc Devices, Inc. | Apparatus and methods to create and maintain an intra-atrial pressure relief opening |
US20110257723A1 (en) | 2006-11-07 | 2011-10-20 | Dc Devices, Inc. | Devices and methods for coronary sinus pressure relief |
US10413284B2 (en) | 2006-11-07 | 2019-09-17 | Corvia Medical, Inc. | Atrial pressure regulation with control, sensing, monitoring and therapy delivery |
US8419710B2 (en) * | 2006-12-06 | 2013-04-16 | Medtronic, Inc. | Methods for infusing fluids via an implantable infusion system |
US8617205B2 (en) | 2007-02-01 | 2013-12-31 | Cook Medical Technologies Llc | Closure device |
WO2008094706A2 (en) * | 2007-02-01 | 2008-08-07 | Cook Incorporated | Closure device and method of closing a bodily opening |
US20090024084A1 (en) * | 2007-07-16 | 2009-01-22 | Peritec Biosciences Ltd. | Multi-lumen catheter assembly and method of providing relative motion thereto |
US8292907B2 (en) * | 2007-08-31 | 2012-10-23 | Cook Medical Technologies Llc | Balloon assisted occlusion device |
CA2751814C (en) * | 2008-12-19 | 2016-11-01 | Kl Medical Llc | Methods and devices for endoscopic access to the heart |
US20100256696A1 (en) | 2009-04-07 | 2010-10-07 | Boston Scientific Neuromodulation Corporation | Anchoring Units For Implantable Electrical Stimulation Systems And Methods Of Making And Using |
US9034034B2 (en) | 2010-12-22 | 2015-05-19 | V-Wave Ltd. | Devices for reducing left atrial pressure, and methods of making and using same |
US20210161637A1 (en) | 2009-05-04 | 2021-06-03 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US10076403B1 (en) | 2009-05-04 | 2018-09-18 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
WO2010128501A1 (en) | 2009-05-04 | 2010-11-11 | V-Wave Ltd. | Device and method for regulating pressure in a heart chamber |
CN102905626A (en) | 2010-01-29 | 2013-01-30 | Dc设备公司 | Devices and systems for treating heart failure |
WO2012051489A2 (en) | 2010-10-15 | 2012-04-19 | Cook Medical Technologies Llc | Occlusion device for blocking fluid flow through bodily passages |
US9629715B2 (en) | 2011-07-28 | 2017-04-25 | V-Wave Ltd. | Devices for reducing left atrial pressure having biodegradable constriction, and methods of making and using same |
US11135054B2 (en) | 2011-07-28 | 2021-10-05 | V-Wave Ltd. | Interatrial shunts having biodegradable material, and methods of making and using same |
US9205236B2 (en) | 2011-12-22 | 2015-12-08 | Corvia Medical, Inc. | Methods, systems, and devices for resizable intra-atrial shunts |
EP2811939B8 (en) | 2012-02-10 | 2017-11-15 | CVDevices, LLC | Products made of biological tissues for stents and methods of manufacturing |
US9332999B2 (en) | 2012-08-13 | 2016-05-10 | Covidien Lp | Apparatus and methods for clot disruption and evacuation |
US9332998B2 (en) | 2012-08-13 | 2016-05-10 | Covidien Lp | Apparatus and methods for clot disruption and evacuation |
ITFR20120013A1 (en) * | 2012-10-23 | 2013-01-22 | Luciana Vitale | CIRCULAR CATHETER FOR MAPPING AND ABLATION GUIDE. |
US20140228937A1 (en) | 2013-02-11 | 2014-08-14 | Joshua Krieger | Expandable Support Frame and Medical Device |
AU2014265849A1 (en) | 2013-05-14 | 2015-11-12 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads with anchoring unit and electrode arrangement and methods of making and using |
US9713696B2 (en) | 2013-05-21 | 2017-07-25 | V-Wave Ltd. | Apparatus and methods for delivering devices for reducing left atrial pressure |
US10448986B2 (en) | 2013-09-27 | 2019-10-22 | Covidien Lp | Electrosurgical medical device with power modulation |
US10568686B2 (en) * | 2013-11-21 | 2020-02-25 | Biosense Webster (Israel) Ltd. | Multi-electrode balloon catheter with circumferential and point electrodes |
US10675450B2 (en) | 2014-03-12 | 2020-06-09 | Corvia Medical, Inc. | Devices and methods for treating heart failure |
US9669210B2 (en) | 2014-04-22 | 2017-06-06 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems with folding anchoring units and methods of making and using |
US9649489B2 (en) | 2014-06-02 | 2017-05-16 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems with anchoring units having struts and methods of making and using |
US9533141B2 (en) * | 2014-07-07 | 2017-01-03 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems with elongate anchoring elements |
EP3171786B1 (en) | 2014-07-23 | 2020-05-13 | Corvia Medical, Inc. | Devices for treating heart failure |
WO2016178171A1 (en) | 2015-05-07 | 2016-11-10 | The Medical Research Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center | Temporary interatrial shunts |
US20170340460A1 (en) | 2016-05-31 | 2017-11-30 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US10835394B2 (en) | 2016-05-31 | 2020-11-17 | V-Wave, Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US10737097B2 (en) | 2016-09-16 | 2020-08-11 | Terrell M. Williams | Permanent his-bundle pacing device and method |
US11660121B2 (en) | 2016-10-18 | 2023-05-30 | East End Medical Llc | Transseptal insertion device |
US11291807B2 (en) | 2017-03-03 | 2022-04-05 | V-Wave Ltd. | Asymmetric shunt for redistributing atrial blood volume |
EP3589238A1 (en) | 2017-03-03 | 2020-01-08 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US20180303488A1 (en) * | 2017-04-20 | 2018-10-25 | Medtronic, Inc. | Stabilization of a transseptal delivery device |
US10993807B2 (en) | 2017-11-16 | 2021-05-04 | Medtronic Vascular, Inc. | Systems and methods for percutaneously supporting and manipulating a septal wall |
US10898698B1 (en) | 2020-05-04 | 2021-01-26 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
WO2019142152A1 (en) | 2018-01-20 | 2019-07-25 | V-Wave Ltd. | Devices and methods for providing passage between heart chambers |
US11458287B2 (en) | 2018-01-20 | 2022-10-04 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
US20210186515A1 (en) * | 2018-05-29 | 2021-06-24 | Orsus, Llc | Method And System For Closure Of Cardiovascular Apertures |
KR102137740B1 (en) | 2018-11-15 | 2020-07-24 | (주) 타우피엔유메디칼 | Pacemaker lead for cerclage pacing |
US11253699B1 (en) | 2019-03-21 | 2022-02-22 | Terrell M. Williams | Cardiac pacing lead |
US11612385B2 (en) | 2019-04-03 | 2023-03-28 | V-Wave Ltd. | Systems and methods for delivering implantable devices across an atrial septum |
US11090080B2 (en) * | 2019-05-15 | 2021-08-17 | Indian Wells Medical, Inc. | Steerable endoluminal punch with introducer |
CN114096205A (en) | 2019-05-20 | 2022-02-25 | V-波有限责任公司 | System and method for creating room shunt tubes |
CN114269270A (en) | 2019-06-11 | 2022-04-01 | 东端医疗有限公司 | Directional balloon transseptal insertion device for medical procedures with improved transseptal puncture system for puncture member balloon sealing |
BR112022005123A2 (en) * | 2019-09-20 | 2022-06-21 | East End Medical Llc | directional balloon transseptal insertion device for medical procedures with enhanced transseptal puncture system with puncture limb balloon seal |
WO2021067669A1 (en) | 2019-10-04 | 2021-04-08 | East End Medical, Llc | Directional balloon transseptal insertion device for medical procedures with improved handle |
WO2021102009A1 (en) * | 2019-11-18 | 2021-05-27 | Nido Surgical Inc. | System with instrument port for epicardial ablation |
US11766545B2 (en) | 2020-02-18 | 2023-09-26 | East End Medical Llc | Deflectable anchor balloon catheter for vascular procedures |
EP4203847A4 (en) | 2020-08-25 | 2024-02-28 | Shifamed Holdings Llc | Adjustable interatrial shunts and associated systems and methods |
WO2022103973A1 (en) | 2020-11-12 | 2022-05-19 | Shifamed Holdings, Llc | Adjustable implantable devices and associated methods |
US11234702B1 (en) | 2020-11-13 | 2022-02-01 | V-Wave Ltd. | Interatrial shunt having physiologic sensor |
US11446486B1 (en) | 2021-06-03 | 2022-09-20 | Gopi Dandamudi | Multielectrode medical lead |
US11813386B2 (en) | 2022-04-14 | 2023-11-14 | V-Wave Ltd. | Interatrial shunt with expanded neck region |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3952742A (en) * | 1974-06-12 | 1976-04-27 | Taylor Duane F | Needle-carried, transthoracic, cannula-type cardiac resuscitation instrument |
US4836204A (en) * | 1987-07-06 | 1989-06-06 | Landymore Roderick W | Method for effecting closure of a perforation in the septum of the heart |
US5312341A (en) * | 1992-08-14 | 1994-05-17 | Wayne State University | Retaining apparatus and procedure for transseptal catheterization |
US5797960A (en) * | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6090084A (en) * | 1994-07-08 | 2000-07-18 | Daig Corporation | Shaped guiding introducers for use with a catheter for the treatment of atrial arrhythmia |
US5690611A (en) * | 1994-07-08 | 1997-11-25 | Daig Corporation | Process for the treatment of atrial arrhythima using a catheter guided by shaped giding introducers |
US6409722B1 (en) | 1998-07-07 | 2002-06-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US6063081A (en) | 1995-02-22 | 2000-05-16 | Medtronic, Inc. | Fluid-assisted electrocautery device |
US5897553A (en) | 1995-11-02 | 1999-04-27 | Medtronic, Inc. | Ball point fluid-assisted electrocautery device |
US6132438A (en) * | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
NL1003024C2 (en) | 1996-05-03 | 1997-11-06 | Tjong Hauw Sie | Stimulus conduction blocking instrument. |
EP0970544B1 (en) | 1997-03-26 | 2000-11-15 | Kirk Acoustics A/S | A contact spring and a tool for handling it |
US5971983A (en) * | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US5938660A (en) * | 1997-06-27 | 1999-08-17 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
US6096037A (en) | 1997-07-29 | 2000-08-01 | Medtronic, Inc. | Tissue sealing electrosurgery device and methods of sealing tissue |
WO1999018871A1 (en) | 1997-10-10 | 1999-04-22 | Hearten Medical, Inc. | A catheter for causing thermal trauma to a patent foramen ovale and method of using the catheter |
WO1999018870A1 (en) | 1997-10-10 | 1999-04-22 | Hearten Medical, Inc. | A balloon catheter for causing thermal trauma to a patent foramen ovale and method of using the balloon catheter |
US6200315B1 (en) * | 1997-12-18 | 2001-03-13 | Medtronic, Inc. | Left atrium ablation catheter |
US6706039B2 (en) | 1998-07-07 | 2004-03-16 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US6537248B2 (en) | 1998-07-07 | 2003-03-25 | Medtronic, Inc. | Helical needle apparatus for creating a virtual electrode used for the ablation of tissue |
US6537272B2 (en) | 1998-07-07 | 2003-03-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US6595934B1 (en) | 2000-01-19 | 2003-07-22 | Medtronic Xomed, Inc. | Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US6692450B1 (en) | 2000-01-19 | 2004-02-17 | Medtronic Xomed, Inc. | Focused ultrasound ablation devices having selectively actuatable ultrasound emitting elements and methods of using the same |
US6361531B1 (en) | 2000-01-21 | 2002-03-26 | Medtronic Xomed, Inc. | Focused ultrasound ablation devices having malleable handle shafts and methods of using the same |
US6558382B2 (en) | 2000-04-27 | 2003-05-06 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
US6514250B1 (en) | 2000-04-27 | 2003-02-04 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
US6488680B1 (en) | 2000-04-27 | 2002-12-03 | Medtronic, Inc. | Variable length electrodes for delivery of irrigated ablation |
EP1278471B1 (en) | 2000-04-27 | 2005-06-15 | Medtronic, Inc. | Vibration sensitive ablation apparatus |
WO2001082811A1 (en) | 2000-04-27 | 2001-11-08 | Medtronic, Inc. | System and method for assessing transmurality of ablation lesions |
US7628780B2 (en) | 2001-01-13 | 2009-12-08 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20040138621A1 (en) | 2003-01-14 | 2004-07-15 | Jahns Scott E. | Devices and methods for interstitial injection of biologic agents into tissue |
US6807968B2 (en) | 2001-04-26 | 2004-10-26 | Medtronic, Inc. | Method and system for treatment of atrial tachyarrhythmias |
US6648883B2 (en) | 2001-04-26 | 2003-11-18 | Medtronic, Inc. | Ablation system and method of use |
US7250048B2 (en) | 2001-04-26 | 2007-07-31 | Medtronic, Inc. | Ablation system and method of use |
US6699240B2 (en) | 2001-04-26 | 2004-03-02 | Medtronic, Inc. | Method and apparatus for tissue ablation |
US6663627B2 (en) | 2001-04-26 | 2003-12-16 | Medtronic, Inc. | Ablation system and method of use |
US6656175B2 (en) | 2001-12-11 | 2003-12-02 | Medtronic, Inc. | Method and system for treatment of atrial tachyarrhythmias |
US7967816B2 (en) | 2002-01-25 | 2011-06-28 | Medtronic, Inc. | Fluid-assisted electrosurgical instrument with shapeable electrode |
US6827715B2 (en) | 2002-01-25 | 2004-12-07 | Medtronic, Inc. | System and method of performing an electrosurgical procedure |
US7294143B2 (en) | 2002-05-16 | 2007-11-13 | Medtronic, Inc. | Device and method for ablation of cardiac tissue |
US7118566B2 (en) | 2002-05-16 | 2006-10-10 | Medtronic, Inc. | Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue |
US7083620B2 (en) | 2002-10-30 | 2006-08-01 | Medtronic, Inc. | Electrosurgical hemostat |
US8021359B2 (en) | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
US7186251B2 (en) | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US6939348B2 (en) | 2003-03-27 | 2005-09-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
WO2004087235A2 (en) | 2003-03-27 | 2004-10-14 | Cierra, Inc. | Methods and apparatus for treatment of patent foramen ovale |
US7165552B2 (en) | 2003-03-27 | 2007-01-23 | Cierra, Inc. | Methods and apparatus for treatment of patent foramen ovale |
US7293562B2 (en) | 2003-03-27 | 2007-11-13 | Cierra, Inc. | Energy based devices and methods for treatment of anatomic tissue defects |
US7497857B2 (en) | 2003-04-29 | 2009-03-03 | Medtronic, Inc. | Endocardial dispersive electrode for use with a monopolar RF ablation pen |
ES2308505T3 (en) | 2004-05-14 | 2008-12-01 | Medtronic, Inc. | ULTRASONIC ENERGY USE SYSTEM FOCUSED ON HIGH INTENS IDAD TO FORM A CUTTED FABRIC AREA. |
WO2005120375A2 (en) | 2004-06-02 | 2005-12-22 | Medtronic, Inc. | Loop ablation apparatus and method |
-
2002
- 2002-05-21 WO PCT/US2002/016142 patent/WO2002094363A2/en active Application Filing
- 2002-05-21 CA CA002446920A patent/CA2446920A1/en not_active Abandoned
- 2002-05-21 US US10/152,553 patent/US20030130713A1/en not_active Abandoned
-
2006
- 2006-04-07 US US11/399,865 patent/US20060184221A1/en not_active Abandoned
-
2007
- 2007-10-24 US US11/923,320 patent/US8096959B2/en not_active Expired - Fee Related
-
2012
- 2012-01-05 US US13/343,815 patent/US20120101434A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3952742A (en) * | 1974-06-12 | 1976-04-27 | Taylor Duane F | Needle-carried, transthoracic, cannula-type cardiac resuscitation instrument |
US4836204A (en) * | 1987-07-06 | 1989-06-06 | Landymore Roderick W | Method for effecting closure of a perforation in the septum of the heart |
US5312341A (en) * | 1992-08-14 | 1994-05-17 | Wayne State University | Retaining apparatus and procedure for transseptal catheterization |
US5797960A (en) * | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
Cited By (140)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9827040B2 (en) | 2002-04-08 | 2017-11-28 | Medtronic Adrian Luxembourg S.a.r.l. | Methods and apparatus for intravascularly-induced neuromodulation |
US9827041B2 (en) | 2002-04-08 | 2017-11-28 | Medtronic Ardian Luxembourg S.A.R.L. | Balloon catheter apparatuses for renal denervation |
US9757193B2 (en) | 2002-04-08 | 2017-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Balloon catheter apparatus for renal neuromodulation |
US10420606B2 (en) | 2002-04-08 | 2019-09-24 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US10105180B2 (en) | 2002-04-08 | 2018-10-23 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravascularly-induced neuromodulation |
US10376311B2 (en) | 2002-04-08 | 2019-08-13 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravascularly-induced neuromodulation |
US10188457B2 (en) | 2003-09-12 | 2019-01-29 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation |
US9125666B2 (en) | 2003-09-12 | 2015-09-08 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US9510901B2 (en) | 2003-09-12 | 2016-12-06 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation |
US8781604B2 (en) * | 2004-08-18 | 2014-07-15 | Cardiac Pacemakers, Inc. | Method of implanting stimulation lead with biased curved section through the interatrial septum |
US20090198297A1 (en) * | 2004-08-18 | 2009-08-06 | Yongxing Zhang | Transeptal lead |
US9125667B2 (en) | 2004-09-10 | 2015-09-08 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
US8939970B2 (en) | 2004-09-10 | 2015-01-27 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9486355B2 (en) | 2005-05-03 | 2016-11-08 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US20070038280A1 (en) * | 2005-08-12 | 2007-02-15 | Cardiac Pacemakers, Inc. | Co-radial lead with extendable/retractable fixation mechanism and apparatus therefor |
US7983764B2 (en) * | 2005-08-12 | 2011-07-19 | Cardiac Pacemakers, Inc. | Co-radial lead with extendable/retractable fixation mechanism and apparatus therefor |
US9808300B2 (en) | 2006-05-02 | 2017-11-07 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US10413356B2 (en) | 2006-10-18 | 2019-09-17 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
US10213252B2 (en) | 2006-10-18 | 2019-02-26 | Vessix, Inc. | Inducing desirable temperature effects on body tissue |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US9327100B2 (en) | 2008-11-14 | 2016-05-03 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9277961B2 (en) | 2009-06-12 | 2016-03-08 | Advanced Cardiac Therapeutics, Inc. | Systems and methods of radiometrically determining a hot-spot temperature of tissue being treated |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8880185B2 (en) | 2010-06-11 | 2014-11-04 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9636173B2 (en) | 2010-10-21 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal neuromodulation |
US9855097B2 (en) | 2010-10-21 | 2018-01-02 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
US10342612B2 (en) | 2010-10-21 | 2019-07-09 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9848946B2 (en) | 2010-11-15 | 2017-12-26 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9649156B2 (en) | 2010-12-15 | 2017-05-16 | Boston Scientific Scimed, Inc. | Bipolar off-wall electrode device for renal nerve ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US9919144B2 (en) | 2011-04-08 | 2018-03-20 | Medtronic Adrian Luxembourg S.a.r.l. | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
US10588682B2 (en) | 2011-04-25 | 2020-03-17 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
US9579030B2 (en) | 2011-07-20 | 2017-02-28 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
US9186209B2 (en) | 2011-07-22 | 2015-11-17 | Boston Scientific Scimed, Inc. | Nerve modulation system having helical guide |
US9186210B2 (en) | 2011-10-10 | 2015-11-17 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US8951251B2 (en) | 2011-11-08 | 2015-02-10 | Boston Scientific Scimed, Inc. | Ostial renal nerve ablation |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
US9028472B2 (en) | 2011-12-23 | 2015-05-12 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9592386B2 (en) | 2011-12-23 | 2017-03-14 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9037259B2 (en) | 2011-12-23 | 2015-05-19 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9186211B2 (en) | 2011-12-23 | 2015-11-17 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9402684B2 (en) | 2011-12-23 | 2016-08-02 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9174050B2 (en) | 2011-12-23 | 2015-11-03 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9072902B2 (en) | 2011-12-23 | 2015-07-07 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US8926605B2 (en) | 2012-02-07 | 2015-01-06 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for radiometrically measuring temperature during tissue ablation |
US8932284B2 (en) | 2012-02-07 | 2015-01-13 | Advanced Cardiac Therapeutics, Inc. | Methods of determining tissue temperatures in energy delivery procedures |
US9226791B2 (en) | 2012-03-12 | 2016-01-05 | Advanced Cardiac Therapeutics, Inc. | Systems for temperature-controlled ablation using radiometric feedback |
US8961506B2 (en) | 2012-03-12 | 2015-02-24 | Advanced Cardiac Therapeutics, Inc. | Methods of automatically regulating operation of ablation members based on determined temperatures |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US9014814B2 (en) | 2012-06-01 | 2015-04-21 | Advanced Cardiac Therapeutics, Inc. | Methods of determining tissue contact based on radiometric signals |
US8954161B2 (en) | 2012-06-01 | 2015-02-10 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for radiometrically measuring temperature and detecting tissue contact prior to and during tissue ablation |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US10188829B2 (en) | 2012-10-22 | 2019-01-29 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US11147948B2 (en) | 2012-10-22 | 2021-10-19 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US9827039B2 (en) | 2013-03-15 | 2017-11-28 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9297845B2 (en) | 2013-03-15 | 2016-03-29 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
US10548663B2 (en) | 2013-05-18 | 2020-02-04 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters with shafts for enhanced flexibility and control and associated devices, systems, and methods |
US10022182B2 (en) | 2013-06-21 | 2018-07-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US9943365B2 (en) | 2013-06-21 | 2018-04-17 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US10342609B2 (en) | 2013-07-22 | 2019-07-09 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
US10722300B2 (en) | 2013-08-22 | 2020-07-28 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US10945786B2 (en) | 2013-10-18 | 2021-03-16 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11154353B2 (en) | 2014-01-27 | 2021-10-26 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods |
US10166069B2 (en) | 2014-01-27 | 2019-01-01 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US9907609B2 (en) | 2014-02-04 | 2018-03-06 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US10736690B2 (en) | 2014-04-24 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters and associated systems and methods |
US11464563B2 (en) | 2014-04-24 | 2022-10-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters and associated systems and methods |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US10660701B2 (en) | 2014-11-19 | 2020-05-26 | Epix Therapeutics, Inc. | Methods of removing heat from an electrode using thermal shunting |
US10499983B2 (en) | 2014-11-19 | 2019-12-10 | Epix Therapeutics, Inc. | Ablation systems and methods using heat shunt networks |
US9522037B2 (en) | 2014-11-19 | 2016-12-20 | Advanced Cardiac Therapeutics, Inc. | Treatment adjustment based on temperatures from multiple temperature sensors |
US9522036B2 (en) | 2014-11-19 | 2016-12-20 | Advanced Cardiac Therapeutics, Inc. | Ablation devices, systems and methods of using a high-resolution electrode assembly |
US9592092B2 (en) | 2014-11-19 | 2017-03-14 | Advanced Cardiac Therapeutics, Inc. | Orientation determination based on temperature measurements |
US9517103B2 (en) | 2014-11-19 | 2016-12-13 | Advanced Cardiac Therapeutics, Inc. | Medical instruments with multiple temperature sensors |
US11701171B2 (en) | 2014-11-19 | 2023-07-18 | Epix Therapeutics, Inc. | Methods of removing heat from an electrode using thermal shunting |
US11642167B2 (en) | 2014-11-19 | 2023-05-09 | Epix Therapeutics, Inc. | Electrode assembly with thermal shunt member |
US11534227B2 (en) | 2014-11-19 | 2022-12-27 | Epix Therapeutics, Inc. | High-resolution mapping of tissue with pacing |
US10166062B2 (en) | 2014-11-19 | 2019-01-01 | Epix Therapeutics, Inc. | High-resolution mapping of tissue with pacing |
US10413212B2 (en) | 2014-11-19 | 2019-09-17 | Epix Therapeutics, Inc. | Methods and systems for enhanced mapping of tissue |
US11135009B2 (en) | 2014-11-19 | 2021-10-05 | Epix Therapeutics, Inc. | Electrode assembly with thermal shunt member |
US9510905B2 (en) | 2014-11-19 | 2016-12-06 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for high-resolution mapping of tissue |
US10383686B2 (en) | 2014-11-19 | 2019-08-20 | Epix Therapeutics, Inc. | Ablation systems with multiple temperature sensors |
US10231779B2 (en) | 2014-11-19 | 2019-03-19 | Epix Therapeutics, Inc. | Ablation catheter with high-resolution electrode assembly |
US11576714B2 (en) | 2015-03-25 | 2023-02-14 | Epix Therapeutics, Inc. | Contact sensing systems and methods |
US10675081B2 (en) | 2015-03-25 | 2020-06-09 | Epix Therapeutics, Inc. | Contact sensing systems and methods |
US9636164B2 (en) | 2015-03-25 | 2017-05-02 | Advanced Cardiac Therapeutics, Inc. | Contact sensing systems and methods |
US9993178B2 (en) | 2016-03-15 | 2018-06-12 | Epix Therapeutics, Inc. | Methods of determining catheter orientation |
US11389230B2 (en) | 2016-03-15 | 2022-07-19 | Epix Therapeutics, Inc. | Systems for determining catheter orientation |
US11179197B2 (en) | 2016-03-15 | 2021-11-23 | Epix Therapeutics, Inc. | Methods of determining catheter orientation |
US11617618B2 (en) | 2017-04-27 | 2023-04-04 | Epix Therapeutics, Inc. | Contact assessment between an ablation catheter and tissue |
US10893903B2 (en) | 2017-04-27 | 2021-01-19 | Epix Therapeutics, Inc. | Medical instruments having contact assessment features |
US10888373B2 (en) | 2017-04-27 | 2021-01-12 | Epix Therapeutics, Inc. | Contact assessment between an ablation catheter and tissue |
Also Published As
Publication number | Publication date |
---|---|
US20120101434A1 (en) | 2012-04-26 |
CA2446920A1 (en) | 2002-11-28 |
WO2002094363A2 (en) | 2002-11-28 |
US20030130713A1 (en) | 2003-07-10 |
US20080045898A1 (en) | 2008-02-21 |
US8096959B2 (en) | 2012-01-17 |
WO2002094363A3 (en) | 2003-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8096959B2 (en) | Trans-septal catheter with retention mechanism | |
US6241728B1 (en) | Left atrium ablation catheter and method | |
US6771996B2 (en) | Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination | |
US6066126A (en) | Precurved, dual curve cardiac introducer sheath | |
EP1326550B1 (en) | Heart wall ablation/mapping catheter | |
JP3572963B2 (en) | Rail catheter ablation and mapping system | |
US6308091B1 (en) | Mapping and ablation catheter system | |
US6773433B2 (en) | Ablation catheter and method for isolating a pulmonary vein | |
EP0868922B1 (en) | Enhanced contact steerable bowing electrode catheter assembly | |
JP3166597B2 (en) | Lead introducer system for treatment of left ventricular tachycardia | |
US5782828A (en) | Ablation catheter with multiple flexible curves | |
JP3259250B2 (en) | Right atrial guidance introducer system | |
JPH07222803A (en) | Guiding and introducing equipment for left atrium of heart | |
US20070270793A1 (en) | Methods for endocardial ablation | |
WO1999025411A1 (en) | Catheter guiding introducers for use in pediatric hearts | |
JPH08266550A (en) | Guidance introduction equipment system to treat attached route around bicuspid by retreat approach method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |